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The purpose ofthis study wastodetermine whetherlow doses ofcarbonmonoxide (CO) exacerbate
myocardial ischemia during a progressive exercise test. The effect of CO exposure was evaluated
using the objective measure of time to development of electrocardiographic changes indicative of
ischemia and the subjective measure of time to onset of angina.
Sixty-three male subjects (41-75 years) with well-documented coronary artery disease, who had
exertional anginapectorisandischemicST-segmentchangesintheirelectrocardiograms, were stud-
ied. Results from three randomized, double-blind test visits (room air, low and high CO) were com-
pared. The effect of CO exposure was determined from the percent difference in the end points ob-
tained onexercise testsperformed beforeandaftera 1-hrexposure to roomair or CO. The exposures
resulted in postexercise carboxyhemoglobin (COHb) levels of0.6% ± 0.3%, 2.0% ± 0.1%, and 3.9% ±
0.1%. The results obtained on the 2%-COHb day and 3.9%-COHb day were compared to those on the
roomair day. There were 5.1% (p = 0.01) and 12.1% (p < 0.0001) decreases inthe time todevelopment
of ischemic ST-segment changes after exposures producing 2.0 and 3.9% COHb, respectively, com-
pared to the control day. In addition, there were 4.2% (p = 0.027) and 7.1% (p = 0.002) decreases in
time to the onset ofangina after exposures producing 2.0 and 3.9% COHb, respectively, compared to
the control day. A significant dose-response relationship was found for the individual differences
in the time to ST end point and angina for the pre- versus postexposure exercise tests at the three
carboxyhemoglobin levels. These findings demonstrate that low doses ofCO produce significant ef-
fects on cardiac function during exercise in subjects with coronary artery disease.
Introduction
Regulatory Background of the Study
A study of the effect of carbon monoxide (CO) expo-
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sureonsubjectswithstable anginapectoriswasunder-
takenatthreeclinicalcenterstodeterminewhetheror
not relatively low doses ofCO would result in myocar-
dialischemia. Thepurposesweretotestthehypothesis
thatlowdoses ofCO canaffectcardiacfunction inindi-
viduals with documented coronary artery disease and
to provide objective electrocardiographic (ECG) infor-
mation for consideration in setting the National Am-
bient Air Quality Standards (NAAQS) for CO.
The NAAQS for CO, promulgated by the U.S. Envi-
ronmental ProtectionAgency (EPA) in 1971, are set at
levels of9 ppm for an 8-hr averaging time and 35 ppm
for a 1-hr averaging time. Extrapolation ofthese expo-
sure levelstocarboxyhemoglobin (COHb)levels is use-
ful because COHb provides a biological marker that
represents the best measurement of CO dose in indi-
viduals and enables the comparison ofresults among
studiesthatemployeddifferentexposureregimens. Ac-
cording to estimates by the EPA(1), a typical adult in-
volved in moderate activity would have a COHb level
of approximately 2.0% after a 1-hr exposure to CO atALLRED ET AL.
35 ppm. Results from exposure models estimate that
60% ofindividuals with cardiovascular disease would
exceed these levels ofCOHb (2). In the ambient atmo-
sphere, CO levels usually fluctuate over the 8-hr aver-
aging time. Various patterns of CO exposure that re-
sult in a 9-ppm 8-hr average would produce COHb con-
centrations intherange of1.4to 1.9% intypical adults.
Originally, the CO standards were based on human
neurobehavioral studies by Beard and Wertheim (3).
These investigatorsreportedimpairment intheability
todiscriminate time intervals atCOHb levels aslow as
1.8%. Although later studies did not support altera-
tions in vigilance at levels below about 5% COHb (4),
otherdatasuggestedeffects inhumans atCOHblevels
of2 to 3%. Subsequent studiesbyAronow andIsbell(5)
and by Anderson and co-workers (6), which showed a
decrease inthe time tothe onset ofangina (chest pain)
during exercise in subjects with coronary artery dis-
ease, were used tojustify the NAAQS for CO.
Aronow and Isbell (5) reported a statistically signifi-
cant reduction in time to angina in a group of 10 sub-
jects with coronary artery disease who had average
COHb concentrations of2.7% after a 2-hr exposure to
50 ppm CO. The study design involved comparing the
time to onset ofangina during exercise tests adminis-
teredbefore and afterexposure either toclean air or to
air containing elevated levels ofCO. In a later study,
Aronow (7) reported a similar decrease in the time to
angina duringexercise in 15 subjects after exposure to
50 ppm CO for 1 hr, resulting in average COHb levels
ofonly about 2.0%. Other evidence for an effect ofCO
at COHb levels less than 3% was provided by a study
of10 subjects with anginabyAnderson andco-workers
(6). The Anderson study had a somewhat different de-
signthanthe Aronow studies(5,7) inthatthere was no
pre-exposure exercise test. On different days, each sub-
ject was exposed to normal air, air with 50 ppm CO, or
air with 100 ppm CO for 4 hr and had average postex-
posure blood COHb levels of1.3, 2.9, and 4.5%, respec-
tively. Average exercise time was significantly short-
ened by the same amount after either CO exposure.
Given the small number of subjects and the subjec-
tive nature of the end point (angina pectoris) in the
Aronow and Anderson studies (5-7), further investi-
gation of the health effects of CO was indicated. In
addition, an expert committee convened by the EPA
concluded that the EPA should not consider the Aron-
ow results as definitive evidence ofthe biologic effects
ofCO, but might consider using them in developing a
margin of safety (1). Because of the potential impor-
tance of reports showing CO effects on subjects with
angina pectoris in thejustification ofthe NAAQS for
CO, a study was organized by the Health Effects Insti-
tute(HEI)toprovideobjective measurements ofthe po-
tential effect ofCO exposure in subjects with coronary
artery disease (8,9). Specifically, the study was de-
signed to answer the question: Do CO exposures that
produce 2 or 4% COHb decrease the time to onset of
ischemia during exercise, as documented by ECG ST-
segment changes and the onset of angina?
Scientific Basis of the Study
Carbon monoxide'stoxicity is related to its ability to
bind tightly to hemoglobin, forming COHb. This reac-
tionnotonly decreasesthe oxygen-carryingcapacity of
the blood, but also shifts the oxyhemoglobin (O2Hb)
dissociation curve to the left (10). The shift to the left
means that oxygen is released less readily from circu-
lating hemoglobin, thereby reducing oxygen delivery
to peripheral tissues. The net consequence ofthese ef-
fects is to produce a state ofrelative hypoxia in the tis-
sues. Othermechanisms oftoxicity may also exist. Use
ofCOHb as the measure ofdose does not imply that a
decrease in the oxygen-carrying capacity ofthe blood
is the sole mechanism for effects of CO.
Low doses ofCO (< 5% COHb) are generally not as-
sociated with adverse effects in normal individuals.
However, there are several conditions that may make
anindividual more susceptible tothe adverse effects of
CO exposure. These include exposure to high altitude,
where ambient oxygen tension is reduced; anemia,
where the oxygen-carrying capacity ofthe blood is de-
creased; chronic lung disease, where gas-exchange
abnormalities cause hypoxemia; and occlusive vascu-
lar disease, in which blood flow to the tissue is re-
stricted. The last condition, as it pertains to the heart,
is the focus ofthis study.
The hypothesis tested in this study is that low doses
ofCOreduce exerciseperformance insubjectswithcor-
onary artery disease. The rationale forthis hypothesis
is based upon the inability of an individual with cor-
onary artery disease to increase coronary blood flow
sufficiently to meet increased levels of myocardial
oxygen consumption. Increased myocardial oxygen de-
mand is normally met primarily by increasing coro-
nary blood flow because the extraction of oxygen by
cardiac muscle, even at rest, is near maximum. As a
subjectexercises, myocardialoxygendemandincreases
in order to maintain an adequate cardiac output. As
longastheincreasingmiyocardial oxygendemands are
met, the heart continues to function normally. At the
pointwhere myocardialbloodflow cannot meet oxygen
demands, the myocardium becomes ischemic. Altered
cellular metabolism associated with myocardial is-
chemia results in the development of chest pain or
characteristic ECG changes, or both. Symptoms of
myocardialischemia(anginapectoris)occurinindivid-
uals with coronary artery disease at specific levels of
exercise andprogress to levelsthat limittheir exercise
capacity. It is possible that increased levels of COHb
may produce ischemic symptoms at lower levels of
work because ofthe reduced oxygen-carrying capacity
of the blood.
Methods
Study Design
Thegoalofthisstudy wastoevaluatethe effectoflow
doses of CO, producing 2 and 4% COHb, on subjects
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FIGURE 1. Trace of a normal ECG pattern displaying ST segment.
withcoronary arterydisease. Twoendpointswereused
toassess adverse effects. Thetimetodevelopment ofan
ST-segment change in the ECG (Fig. 1) that exceeded
a specific threshold level (see "Exercise Treadmill
Testing" under "Methods") will be referred to as time
to"STendpoint' TheSTendpointwaschosenbecause
it is an objective indicator ofmyocardial ischemia. The
second end point was the time to onset ofangina pec-
toris. This provides an indicator of symptomatic myo-
cardial ischemia and was the primary cardiac end
point used in earlier studies.
Subjects enrolled in this study had coronary artery
diseasewithstableexertional anginaandreproducible
exercise-induced ST-segment changes. To ensure an
adequate sample size, 20 to 25 subjects were studied at
each ofthree centers. A standardized protocol was de-
veloped, and the same experimental methods were fol-
lowed at each center.
The study consisted offour visits for each subject: a
base-line qualifying visit (visit 1) and three random-
ized, double-blindtestvisits(visits2,3, and4). Thepro-
tocol for the qualifying and test visits is outlined in
Table 1. Figure 2 illustratestheprotocolfora testvisit.
The basic design ofthe study was to use repeated exer-
cise tests each day to minimize variability in end
points (11). On each test day, the subject was screened
for elevated base-line COHb levels, performed a symp-
tom-limitedexercise test on atreadmill, after recovery
was exposed in an environmentally controlled cham-
ber for approximately 1 hr to room air or CO in room
air, and then performed a second exercise test. The ex-
posure conditions for test visits were randomized
among room air and two levels ofCO expected to pro-
duce 2.2 and 4.4% COHb before exercise and approxi-
mately 2.0 and 4.0% at the end ofexercise. Based upon
lTble 1. Protocol for qualifying and test visits.
Qualifying visit Test visits
(visit 1) (visits 2, 3, 4)
History, physical exam History, physical exam
COHb level COHb level
Exercise test 1 Exercise test 1
Sham exposure Randomized exposure
Air
CO, 2% COHb
CO, 4% COHb
Exercise test 2 Exercise test 2
CO uptake exposure
300H
2001-
100-
E
C
0
.0
0'
I- I k-H
Intertm Pre- CO exposure Post-
history, exposure exposure
physical exercise exercise
exam test test
0 20 40 60 80 100 120 140
Time from arrival at laboratory (min)
FIGURE 2. Illustration ofprotocol for test visit on 4%-COHb target
day.
pilot experiments in normal subjects, a 10% decrease
in percent carboxyhemoglobin during exercise was
projected.
The analysiswasdesignedtoprovide maximalpower
to reduce the number of subjects required to test the
hypothesis that low doses of CO reduce exercise per-
formance. For each test day, the difference inresults of
the pre- and postexercise tests for the two end points
(time to ST end point and time to angina) was deter-
mined, and then these differences on the 2- and 4%-
COHb-target days were compared tothe results onthe
control day. This analysis is preferable to a direct com-
parison ofthe time to end point on different test days
because of greater day-to-day variation than within-
day variation ofthese two end points in these subjects
(11). Theprotocol wasreviewedbythe Institutional Re-
view Board at each test center. Throughout the meth-
ods section, values are presented as means + stan-
dard deviations.
Visit 1. The qualifying visit (Table 1) included ob-
taining the subject's informed consent, followed by a
complete medical history and physical examination
and a baseline 12-leadECG. Ifthe subject qualifiedby
the inclusion-exclusion criteria described below, a
blood sample was taken to determine whether or not
the subject's baseline blood COHb level was above the
level specified by the exclusion criterion. This require-
ment is identical tothat invisits 2, 3, and4, and is dis-
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cussed in detail below. A symptom-limited exercise
treadmilltest, using amodifiedNaughtonprotocol(12)
wasthenperformed. Afterthe exercise test,the subject
rested until his ECG returned to baseline values. The
subject then entered the environmental chamber for a
1-hr sham exposure period prior to a second, identical
exercisetest. Qualificationforentryintothestudy con-
sisted ofreproducible results onthe two exercise tests:
Both tests had to be positive with respect to both ST
end point and angina; in addition, the difference in
duration ofthe twoexercise testshadtobe 150 seconds
or less.
Subjects who met the entrance criteria were then ex-
posedintheenvironmental chamberto 150 ppmCOfor
60 minwithfull knowledge ofthe exposure conditions.
The subjects remained seated during the exposure.
Venous blood samples were collected every 15 min and
analyzed immediately for %COHb by CO oximetry.
These data were usedto determine the subject's CO up-
take constant; this was used on subsequent visits to
calculate the atmospheric CO levels required for each
subject to absorb sufficient CO in 1 hr to reach the de-
sired COHb level.
Visits 2, 3, and 4. Subjects who met the reproduci-
bility requirements during the initial visit returned
for three test visits (Table 1). These visits were sepa-
ratedby atleast72hr, andalloccurredwithin a4-week
period. The subjects were instructed to continue their
cardiac medicationsthroughoutthe study. Every effort
was made to maintain consistency ofdose and time of
use before a test visit. Subjects were also instructed to
refrain from eating or drinking for 2 hr before coming
to the laboratory.
Upon arrival at the laboratory, the subject's baseline
COHb level was measured by CO oximetry to assure
that it was at or below the equivalent ofthe gas chro-
matography (GC) level of 1% (see below). A pretest in-
terim history and 12-lead ECG were done at each visit
toverify thatthe subject wasclinically stable. The sub-
ject then performed a symptom-limited exercise test
and was allowed to recover. The original protocol per-
mitted a subject to complete the test visit whether or
not he achieved the ST end point or developed angina
duringthe first exercise test. As a precaution, the pro-
tocol was amended, effective February 18, 1986, to
minimize the potential failure to achieve the cardiac
end points. When a subject did not develop angina or
achieve the ST end point on the pre-exposure exercise
test ofvisits 2, 3, or4,the exposure and second exercise
test for that day were not done, and the visit was re-
scheduled. Ifthe subject failed to achieve one or both
of the end points on two successive visits, he was
dropped from the study. This resulted in rescheduling
two subjects and dropping one subject from the study.
The subjects were exposed according to a randomiza-
tion schedule (Appendix A) to room air, to the lower
level ofCO, ortothe higherlevel ofCO afterrecovering
from the first exercise test. The subjects and the per-
sonnel responsible forthe exercise testing and the car-
diovascular monitoring were blinded as to the expos-
ure conditions. Exposure personnel were not blinded
but did not communicate with subjects or cardiology
personnel. The exposure conditions were selected to
produce no change in %COHb, an increase to 2.2%
COHb (2%-COHb-target day), or an increase to 4.4%
COHb (4%-COHb-target day), as measured by GC.
These COHb targets are 10% greater than the desired
levels atthe end ofthe secondexercise test,which were
2.0 and 4.0% COHb, to compensate for the loss of CO
duringexercise. Inorder to attain arelatively constant
level of%COHb at the end of exposure, the level ofCO
in the chamber for each individual was varied accord-
ingtotheuptake constantdeterminedduringthe qual-
ifyingvisit(visit 1). Anadditional variable, durationof
exposure, was also used to help attain the desired level
of %COHb. All procedures used on the CO-exposure
days were followed on the air-exposure days to main-
tain double-blind conditions. After the exposure, the
subjects exercised usingthe same protocol for a second
time. The meantime fromthe end ofthe exposure peri-
od to the beginning ofthe second exercise test was 17
min (SD = ± 10.2; SEM = ± 0.6).
Venous blood samples were collected to monitor the
CO exposure conditions. Carboxyhemoglobin levels
were measured by CO oximetry in each subject during
visits 2, 3, and 4 at the times indicated in Table 2 and
illustrated in Figure 3: arrival at the laboratory (sam-
ple 1); within 1 min ofcompletingthe first exercise test
(sample 2); after 30 minofexposure (sample 3); after40
minofexposure(sample 4); attheendofexposure (sam-
ple 5); andwithin 1 min ofcompleting the second exer-
cise test (sample 6). The protocol called for analysis of
the data using GC based COHb levels. Therefore, key
samplesfromall subjects were senttothe St. Louis Ref-
ilble 2. Blood-sample collection and analysis for visits 2, 3, and 4.
Analysis
Sample Gas chromatography
number Collection time CO oximetry (at reference lab)
1 When subject arrives at lab Immediately No
2 At end ofexercise test 1 (within 1 min) Immediately Yes
3 At 30 min of CO exposure Immediately No
4 At 40 min of CO exposure Immediately No
5 At end of CO exposure Within 1 hr Yesa
6 At end of exercise test 2 (within 1 min) Within 1 hr Yes
a The original protocol did not require GC analysis of sample 5. An amendment, with an effective date of August 29, 1985, added GC
analysis of sample 5. Prior to that date, seven subjects were studied.
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ltble 3. Major participants in the study.
Test Centers
Francis Scott Key Medical Center, The Johns Hopkins University
School ofMedicine, EugeneR. Bleecker, Sidney 0. Gottlieb, SandraM.
Walden
Rancho Los Amigos Medical Center, Jack D. Hackney, Ronald H.
Selvester, Robert B. Pearson
St. Louis University School ofMedicine, Thomas E. Dahms, Bernard
R. Chaitman, Robert Wiens
Reference Laboratory
St. Louis University School of Medicine, Thomas E. Dahms
Statistical and Data Management Center
Harvard University School of Public Health, Marcello Pagano,
Elizabeth N. Allred
Quality-Assurance Group
Arthur D. Little, Inc., Denise Hayes, Andrew Sivak
Advisory Committee
JohnW Tukey(Chairman), StephenAchuff, StephenAyres, Joseph D.
Brain, Steven Horvath, Roger 0. McClellan
Project Manager
Health Effects Institute, Jane Warren
I I
0 20 40 60 80 100 120 1
Time from arrival at laboratory (min)
1
140
FIGURE 3. Sampling of blood during test visit. COHb levels in all
samples were determined by CO oximetry. In addition, samples
2, 5, and 6 were analyzed for CO content by GC methods at the
reference laboratory.
erence Laboratory for analysis by GC. Samples 2 and
6, which were drawn at the end ofexercise tests 1 and
2, respectively, were analyzed by GC in all subjects
throughout the study. Beginning August 29, 1985, a
protocol amendment was introduced to require analy-
sisbyGC ofsample 5(endofexposure). OnlyCO oxime-
try measurements wereperformed onsamples 1, 3, and
4.
To assure that the subjects did not encounter high
levels ofCO prior to arriving at the laboratory, sample
1 was collected and immediately analyzed. The initial
upper limitfor sample 1 was 1.8% COHb by CO oxime-
try, which wasassumed torepresent approximately 1%
COHb by GC. As data accumulated duringenrollment
of the first subjects, comparison of COHb levels ob-
tained by GC and CO oximetry resulted in protocol
amendments that raised the upper limit allowable for
sample 1. Fifty-six ofthe 63 subjects were tested using
exclusion levels ofCOHb, measuredby CO oximetry, of
> 2.0% with O2Hb levels of 60% or less, > 2.2% with
O2Hb levels of 61 to 80%, and > 2.4% with O2Hb
levels above 80%.
Samples 3 and 4 were used to project the subject's
COHb level at the end ofexposure at visits 2, 3, and 4.
Each subject was exposed to a level of CO that should
have resulted in the desired COHb level after 60 min,
based on his uptake constant as measured at visit 1. If
CO uptake measured at 30 and 40 min wasfaster than
expected, then the exposure period was shortened ac-
cordingly. If uptake was slower, the exposure period
was lengthened. Exposures were restricted to either
50, 55, 60, 65, or 70 min in length to limit the options
for randomization on the air day.
Organization of the Study
Many groups participated in this study, as shown in
Table 3. Their roles are described briefly below.
Test Centers. Investigators at three medical centers
(JohnsHopkinsUniversity SchoolofMedicine,Rancho
Los Amigos Medical Center, and St. Louis University
School of Medicine) participated in designing the
study,writingtheprotocolandstandardoperatingpro-
cedures, and recruiting and testing the subjects.
Reference Laboratory. A reference laboratory, op-
erated at St. Louis University School ofMedicine, pro-
vided samples for comparing CO oximeter readings at
the three test centers. The laboratory was also respon-
sible for gas chromatographic measurements ofCO on
all key blood samples from each subject at the three
test centers.
Statistical and Data Management Center. In-
vestigators at the Statistical and Data Management
Center at the Harvard School ofPublic Health partici-
pated in designing the study, writing the protocol, de-
signing the data collection forms, and planning the
data analysis. They also processed and analyzed data
sent on forms from the test centers.
Quality Assurance Group. A group at Arthur D.
Little, Inc., Cambridge, MA, wasresponsible for ensur-
ing the quality of data generated in this study. This
group participated in reviewing the protocol and stan-
dard operating procedures for the study. The Quality
Assurance(QA)Officerperformedsite visitsatthetest
centers, reference laboratory, and Statistical and Data
Management Center in order to determine that the
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protocol andstandardoperatingprocedureswerebeing
followedandthatdatawere reliable andtraceable. The
QA group conducted the final quality assurance audit
on the data at the end ofthe study.
Description of Subjects
Subject Selection Criteria. The selection criteria
for the study population were chosen with the goal of
obtaining a group ofmen who do not smoke and who
have objective evidence of coronary artery disease,
stable angina, and evidence of reproducible, exercise-
induced myocardial ischemia (angina and ischemic ST
changesontheECG)duringexercise treadmill testing.
Women were excluded to reduce the risk offalse-posi-
tive exercise test results that are more common in wo-
men (13,14). The following subject inclusion and ex-
clusion criteria define study population.
INCLUSION CRITERIA.
1) Men, ages 35 to 75 years.
2) Stable exertional angina pectoris.
a) Duration of 3 months or more.
b) Angina class II orgreater (Canadian Cardio-
vascular Society Classification) (15).
3) A positive exercise treadmill test for myocar-
dial ischemia, defined by:
a) Exercise-induced ST-segment depression or
elevation onthe ECGcomparedwiththe rest
tracing, as defined in the methods section
(ST end point)
b) Associated exercise-induced angina. (The
presence of angina was required in order to
addressthe outcome variable oftimetoonset
of angina, which was used in prior studies.)
4) Documentation ofthe presence of coronary ar-
tery disease, demonstrated by one or more of
the following criteria to provide additional ob-
jective evidence of coronary artery disease to
exclude subjects with false-positive exercise
studies:
a) Angiographic evidence of coronary artery
disease with one or more major coronary ar-
tery with diameter narrowing of 70% or
more.
b) Prior myocardial infarction, documented by
at least two ofthe following:
i) typical chest pain lasting 1 hr or more;
ii) new Q waves enduring 0.04 sec or more,
or T-wave inversions lasting longer than
1 week on the 12-lead ECG;
iii) creatine kinase (serum) rise greater than
twice normal with 10% or more MB iso-
enzyme fraction.
c) Positive thallium stress test with unequivo-
cal perfusion defect.
5) Ability andwillingness ofthe subject toprovide
informed consent.
6) Permission ofthe subject's primary physician.
7) Stable anti-ischemic medical regimen for the
study duration, or no medication. (Except for
digoxin, exclusion criterion 7, there were no
limitations regarding medical therapy other
than that all medications were to be continued
in unchanged doses and at standard dosing in-
tervals throughout the study period.)
8) Ability to exercise for at least 3 min using the
modifiedNaughtonprotocol, with reproducible
total exercise duration on two tests performed
at visit 1. (The reproducibility requirement de-
manded that the total exercise duration times
be within 150 sec in order to exclude subjects
with significant variations in serial exercise
performance, inwhomvariant angina mightbe
present andinwhomthe effect ofCO exposures
would be difficult to interpret.)
EXCLUSION CRITERIA.
1) Cigarette, cigar, or pipe smoking within 3
months (by history). (Current smokers were ex-
cluded because of chronic high COHb levels.)
2) Unstable angina, defined by new onset or
change in pattern of angina within 3 months,
or symptoms ofangina at rest. (These patients
were excluded because of their high risk and
unpredictable clinical course.)
3) Myocardial infarction within the previous 3
months (3-month stability of symptoms as re-
quired in exclusion criterion 2).
4) Symptomatic congestive heart failure and con-
genital or significant valvular heart disease.
(Excluded to minimize risk and to obtain a
more homogeneous study population for re-
peated exercise testing.)
5) Previous coronary artery bypass surgery with-
in 6 months. (Early postbypass patients were
excluded because ofcomplications ofrecovery.)
6) RestingECG abnormalities that may interfere
with ST-segment interpretation during exer-
cise, defined by the exclusion of subjects with
resting ECGs that meet the following Minne-
sota code classifications (codes in parentheses)
(16): left ventricular hypertrophy (3-1, 3-2, 3-3,
3-4); ST depression (4-1, modified to read 2.0
mm); invertedT waves(5-1); A-V conduction de-
fects(6-1, 6-2, 6-4, 6-8); interventricularconduc-
tion defects (7-1, 7-2, 7-4); tachyarrhythmias
(8-2, 8-3, 8-4, 8-5, 8-6); and large amplitude T-
waves (9-6).
7) Digoxin therapy or uncorrected hypokalemia.
8) Significant pulmonary disease defined by a
forced expiratory volume in 1 sec (FEV1) less
than or equal to 50% predicted for age, height,
and gender, or previously documented resting
hypoxemia (arterial P02 less than or equal to
60 mmHg), oroxygensaturationlessthan90%.
(The performance of arterial blood gas or ear
oximetry was not required, but could be per-
formed at the investigator's discretion ifsignif-
icant pulmonary disease was suspected.)
9) Uncontrolled hypertension (systolic pressure
greater than 170 mm Hg or diastolic pressure
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greater than 100 mm Hg at rest). (It was felt
that items 8 and 9 potentially limited exercise
performance significantly, and thus volunteers
exhibitingeithercharacteristicwereexcluded).
10) Anemia (hemoglobin less than 10 g/dL).
11) Thyrotoxicosis or other uncontrolled endocrine
disease.
12) Symptomatic cerebrovascular disease, includ-
ing recent stroke or symptoms suggestive of
transient ischemic attacks.
13) Other significant debilitating systemic dis-
ease.
14) Inability or contraindication to perform exer-
cise treadmill testing or to return for follow-up
visits.
15) Initial venous COHb level at visit 1 greater
than the exclusion criterion, as described un-
der "Methods." (The CO oximetry exclusion cri-
terion was chosen to represent 1% or less by
GC.)
16) Presence of a permanent pacemaker.
Subject Recruitment Strategy. Subjects were re-
cruited fromthe three test centers and included outpa-
tients in the cardiology clinics, patients undergoing
clinical exercise treadmill testing, patients scheduled
for cardiac catheterization, and past and present par-
ticipants incardiacrehabilitationprograms. Male sub-
jectswithpositive exercisetreadmill testswerefurther
screenedforsmokinghistory, andpotential candidates
were then approached for visit-1 screening after per-
mission fromthe subject's physician was obtained. Ini-
tial screening of subjects was performed by the study
investigators with the assistance of research techni-
cians and nurses.
Subject Enrollment and Exclusion. Seventy-six
subjects, who reportedly met all visit-1 criteria, were
enrolled in the study. Data from 63 ofthem were used
in the main data analysis, reported in the results sec-
tion ofthisreport. The reasonsfor exclusionofsubjects
are summarized in Table 4.
Seven ofthe 76 enrolled subjects did not complete all
test visits, leaving atotal of69 subjects whocompleted
the three test visits. Ofthe 69 subjects who completed
the four visits, six were excluded from the main data
Table 4. Summary of subject exclusion from study
and main data analysis.
76 subjects enrolled in study after completing visit 1
7 did not complete three test visits
69 subjects completed three test visits
1 disqualified on basis of visit-1 reproducibility requirement
4 disqualified on basis of visit-1 ST criteria
1 disqualified on basis ofsample-1 COHb levels at two test visits
63 subjects provided data for angina analysis of4% effect (62 subjects
provided data for ST analysis of4% effect because one subject did not
provide ST-end point data)
1 excluded from 2% analysis because of sample-1 COHb levels
62 subjects provided data for angina analysis of2% effect (61 subjects
provided data for ST analysis of2% effect because one subject did not
provide ST-end point data)
analysisbecausetheydidnotmeetallprotocolcriteria.
Analysis ofdatafromthe 69 subjects is included inAp-
pendix B. Data from 63 subjects were used in the main
analysis ofthe effect of3.9% COHb on time to angina,
and data from 62 subjects were used in the analysis of
theeffectof2.0% COHbontimetoangina. Becauseone
subject provided no ST data, there are only 62 and 61
subjects in the 3.9% and 2.0% COHb analyses oftime
to ST, respectively. The range in time from enrollment
in the study to study completion was 10 to 35 days.
Characteristics ofStudy Population. The char-
acteristics of the study population are presented in
Tables 5, 6, and 7. Table 5 describesthe criteria metby
eachsubjectwithrespecttoevidenceofcoronaryartery
disease. Table 6 presents information about general
medical and cardiac history and medication use, as
well as demographic information. Table 7 summarizes
quantitative information on age, height, weight, and
cardiac and pulmonary function.
Sixty-three male, nonsmoking subjects with a mean
age of62.1 ± 8.1 years, with stable anginapectoris and
positive exercise treadmill tests that showed ischemic
ST-segment changes, completed the protocol. In addi-
tion, as indicated in Table 5, each subject fulfilled at
least one other criterion for coronary artery disease:
angiographic evidence, prior myocardial infarction, or
apositive thallium stresstest. The majorityofsubjects
was classified as having class II angina (15). Ten had
priorcoronaryarterybypasssurgery. Thirty-threesub-
jectshad ahistory ofpreviousmyocardial infarction; of
this group, 26 had objective evidence of myocardial
infarction, as definedby inclusion criterion 4. Twenty-
seven subjects had a positive thallium perfusion scin-
tigraphic study, and 40 had previous cardiac catheter-
ization that demonstrated obstructive coronary artery
disease. The mean number of anginal episodes per
week at study entry was 4.6 (range of0 to 63), and the
mean number ofnitroglycerin tablets taken per week
was 2.3 (range of 0 to 30). Although 31 subjects re-
ported ahistory ofhypertension, no subjecthad uncon-
trolled hypertension during the study.
Coronary angiography had been performed in 43
subjects, although it was not a necessary prerequisite
for study inclusion. Forty subjects had at least one ves-
sel with 70% or more diameter obstruction by visual
estimation. Thirteen subjects had single-vessel coro-
nary artery disease, 15 had double-vessel coronary
artery disease, and 12 had triple-vessel coronary dis-
ease. No subject had significant left main coronary
disease.
Information on resting ECG abnormalities is sum-
marized in Table 6. Although a significant number of
subjects hadresting P- and T-wave abnormalities typi-
cal for subjects with coronary artery disease, only a
smallnumberhadminorrestingST-segmentelevation
(5) or ST-segment depression (7). In no case wasthe de-
greeofrestingST-segmentchangesfelttobeincompat-
ible with the interpretation of ischemic ST-segment
changes produced during exercise. Pulmonary func-
tion assessed by spirometry demonstrated a mean
95ALLRED ET AL.
Tlble 5. Criteria of coronary artery disease by which each subject qualified for the study.a
Coronary artery disease indicator Coronary artery disease indicator
Myocardial Myocardial
infarction infarction
Angiography (objective Positive Angiography (objective Positive
Subject (> 70% lesion) evidence) thallium test Subject (2 70% lesion) evidence) thallium test
Johns Hopkins Rancho Los Amigos (continued)
101 + 234 +
102 + 235 +
103 + 236 +
104 + + + 237 + +
105 + 239 +
106 + + 241 +
107 + + 243 +
108 + Subtotal 12 7 5
109 +
110 + + + St. Louis
111 + 301 +
112 + 303 +
113 + 304 + + +
114 + 306 +
115 + + + 310 +
116 + 311 + + +
117 + + 317 + + +
118 + 318 + +
121 + 323 + + +
122 + 324 + +
124 + + 325 +
125 + 326 + + +
Subtotal 14 13 5 327 + +
328 +
Rancho Los Amigos 330 +
201 + + 332 +
205 + 333 + +
207 + + + 334 +
213 + 335 +
214 + 336 +
215 + + 337 +
218 + 338 +
221 + 339 +
222 + + Subtotal 14 6 17
227 +
229 + Total 40 26 27
a Any one ofthese three criteria was required for entry. In addition, each subject had stable exertional angina pectoris and a positive exer-
cise treadmill test, asrequiredbythe protocol. (+)Indicates that the subject fulfilledthe criterion. Information is not available to distinguish
an absence of information from failure to meet the criterion.
FEV1 of88% ofpredictedvalues, and a mean forced vi-
talcapacity(FVC)of90% ofpredictedvaluesforage and
size. Thus, significant obstructive or restrictive pul-
monary disease was not found inthe studypopulation.
Although none ofthesubjectshadsmokedfor atleast
3 months prior to study entry, 51 had a history ofpast
cigarette smoking. Forty-eight of these had stopped
smoking more than 12 months before study entry, one
had stopped 6 to 12 months prior to study entry, and
twohadstopped 3 to 6 monthspriortostudyentry. The
low COHb levels in venousbloodsamples upon arrival
at the testing center provided evidence ofcompliance
with thenonsmokingrequirement. Nosubjectwho en-
tered the study had to be excluded on the basis of sus-
pectedresumptionofsmokingduringthestudyperiod.
Most subjects were receiving stable doses of beta-
adrenergic blockers, nitrates, or calcium channel an-
tagonists during the study period. The number ofsub-
jectsusingeachtype ofmedication isreported in Table
6. All subjects were carefully instructed to take their
usual cardiovascular medications at the same time on
the study days, and testing was scheduled at a stan-
dard time ofthe day for each subject to ensure a uni-
form time interval between the administration ofcar-
diovascular medications and exercise testing.
All subjects underwent physical examination at
study entry. As shown in Table 7, they had a mean
weight of83.0 ± 10.2 kg and a mean height of176.1 ±
7.2 cm. Their mean resting heart rate was 63.3 ± 10.9
beats per minute. Mean systolic blood pressure was
131.2 ± 20.8 mm Hg(sitting), and diastolicblood pres-
sure was 77.5 ± 8.6 mm Hg (sitting). No patient had
evidence of congestive heart failure; no S3 gallops,
rales, or evidence ofelevated venous pressure were de-
tected. An S4 gallop was detected in six subjects, three
subjects had systolic murmurs, and one had a diastolic
murmur; all ofthese murmurs were interpreted to be
clinically insignificant. Three subjects had evidence of
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Ibble 6. Baseline characteristics of the study population (63 subjects).
Number of Number of
Characteristics subjects Characteristics subjects
Heart disease
Stable angina pectoris
Angina class II
Angina class III
History of angina at rest
History of myocardial infarction
Prior coronary artery bypass surgery
Information on coronary angiography
> 70% lesion
Single-vessel CAD'
Double-vessel CAD
Triple-vessel CAD
Left main CAD
63
60
3
7
33
10
43
40
13
15
12
0
Resting electrocardiogram
P-wave abnormality
T-wave abnormality
Anterior MIb
Inferior/posterior MI
Resting ST-segment elevation
Resting ST-segment depression
Positive thallium stress test
9
21
10
11
5
7
27
Disease history
Hypertension
Diabetes mellitus
Cerebrovascular disease
Peripheral vascular disease
Valvular heart disease
Pulmonary disease
Thrombophlebitis
Hepatic disease
Renal disease
Gout
Neoplastic disease
Peptic ulcer
Hyperlipidemia
Smoking
Currently nonsmoking
Prior smoking (cigarettes)
When stopped smoking
3 to 6 months prior to study
6 to 12 months prior to study
More than 12 months prior to study
a CAD, coronary artery disease.
b MI, myocardial infarction.
31
10
4
2
1
2
1
1
3
10
1
4
12
63
51
2
1
48
Medications
Beta-blockers
Nitrates (oral)
(patch)
Calcium antagonists
Diuretics
Antiarrhythmics
Antihypertensives
Other cardiac
Demographic information
Occupation
Professional
Clerical
Laborer
Other
Employment status
Full time
Part time
Not employed
Disabled
Retired
Education
Grade school
High school
Some college
College graduate
Graduate school
Unknown
Marital status
Single
Married
Divorced/separated
Widower
Unknown
Religious affiliation
Protestant
Catholic
Jewish
Other
Unknown
Table 7. Quantitative baseline subject characteristics.
Characteristics Mean ± SD
Age 62.1 ± 8.1
Weight, kg 83.0 ± 10.2
Height, cm 176.1 ± 7.2
Angina duration, months 65.5 ± 64.8
Angina episodes/week 4.6 ± 9.4
Nitroglycerin tablets/week 2.3 ± 5.5
Resting heart rate, beats/min 63.3 ± 10.9
Blood pressure, mm Hg
Systolic (sitting)
Diastolic (sitting)
Systolic (standing)
Diastolic (standing)
Spirometry
FEV,, L
FEVI, % predicted
FVC, L
FVC, % predicted
131.2 ± 20.8
77.5 ± 8.6
130.4 ± 17.9
78.1 ± 9.4
2.8 ± 0.5
88.3 ± 18.3
3.7 ± 0.7
90.0 ± 15.7
cardiac enlargement and four had abnormalities of
lung fields on chest X-ray examination.
Although the major clinical characteristics were
comparable at the three testing centers, several minor
differences were noted. There was a lower percentage
of subjects in professional occupations enrolled at
Johns Hopkins University (9%) than at St. Louis Uni-
versity (39%) or Rancho Los Amigos Medical Center
(50%). There were minor differences in measured elec-
trolyte values, including sodium, potassium, and
chloride, butthese values were withinnormal limits at
each center.
Carbon Monoxide Exposure and
Monitoring
Carbon Monoxide Exposure Methods. The pro-
38
30
6
40
13
4
7
7
20
6
31
6
25
3
4
5
26
5
34
15
6
2
1
5
50
3
4
1
30
19
1
11
2
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cedures used for exposing the subjects to CO were in-
tended to result in end-of-exercise COHb values of2.0
or 4.0% as determined by GC. To attain these levels of
COHb inthe subject'sblood, the target levels afterthe
exposure were set at values 10% greater than the de-
siredend-of-exercise levels,thatis, 2.2 and4.4% COHb.
Subjects exercised while they breathed room air that
contained no more than 8 ppm CO, which resulted in
theelimination ofsomeofthebodyburden ofCOtaken
up duringthe exposure phase. The subjects at all three
centers were exposed in room-sized chambers (700 to
2000 ft3) for approximately 1 hr. The chamber concen-
trations were adjusted for each subject based on his
CO-uptake data obtained at visit 1, but were fixed for
the duration ofeach exposure. Due to variability in a
given subject's CO-uptake rate, the length ofeach ex-
posure was also varied, with the goal ofattaining end-
of-exposure levels ofCOHb as close to the target levels
as possible. The effectiveness ofthe exposure protocol
in narrowing the range ofCOHb values is discussed in
Appendix C.
Eachindividual's CO-uptake rate wasdetermined at
the end ofthe qualifying visit to the laboratory (visit
1). The subjects were exposed to 150 ppm CO for 1 hr,
and blood samples were drawn prior to and every 15
min during the exposure period. These samples were
analyzed immediately by CO oximetry for %COHb.
The %COHb values were plotted against duration of
exposure, and the 60-min uptake rate was computed
based upon a linear regression of the slope, with the
units of change in %COHb per hour. This value was
divided by the actual level ofCO to which the subject
was exposed (approximately 150 ppm), resulting in an
uptake-rate constant expressed as change in %COHb
per hour per ppm CO.
On the randomized test visits, the level ofCO in the
chamber required to increase the %COHb from the
sample 2 (preexposure) level to the target level was
computedbythe following equation: CO concentration
(ppm) = [(target %COHb) - (sample 2 %COHb)]/(up-
take rate constant).
Since the uptake-rate constant was determined on
thebasisofonlyoneexposure, allowance forvariability
in the uptake rate on subsequent visits was provided
forby measuring uptake at 30 and40 min and varying
the length of exposure from 50 to 70 min. The appro-
priate length ofexposure to CO wasestablished graph-
ically by linear extrapolation from a plot ofthe COHb
levels at 0, 30, and 40 min (Fig. 4).
To minimize learning ortraining effects onthe study
results, the order ofexposure amongthe three possible
conditions ofexposure was randomized (Appendix A).
The Statistical and Data Management Center assigned
a randomization order for each subject as he qualified
for entrance into the study (successful completion of
visit 1). The effectiveness ofthe randomization process
for determining the order ofexposure to air, 2% COHb
target CO level, and 4%-COHb target CO level is sum-
marized in Table 8. A comparable number of subjects
.
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FIGURE 4. Determination of length of exposure for a given subject.
The GC target is 4.4% COHb, corresponding to a CO oximeter
targetof5.7%. The preexposure samplewas analyzed andplotted
at time 0. This point was connected to the possible end-of-expos-
uretimesof50, 55,60,65, or 70 min(open square andsolidlines).
Additional decision lineswere also drawn at52.5, 57.5, 62.5, and
68.5 minandthe initial datapoint(open circle anddashed lines).
The values ofCOHb obtained at 30 and40 min were then plotted
on this graph (filled triangle). Since these data points fell be-
tween the 57.5- and 62.5-min decision lines, the exposure was
carried out for 60 min.
Table 8. Results ofrandomization oforder ofblinded exposures
to purified air, carbon monoxide to 2%-COHb target, and carbon
monoxide to 4%-COHb target.
Number of subjects
Exposure Visit 2 Visit 3 Visit 4
Combined
Air 20 24 19
2% COHb 20 22 20
4% COHb 23 16 24
Johns Hopkins
Air 7 8 7
2%COHb 8 8 6
4%COHb 7 6 9
Rancho Los Amigos
Air 5 7 6
2%COHb 4 7 7
4% COHb 9 4 5
St. Louis
Air 8 9 6
2%f/oCOHb 8 7 7
4% COHb 7 6 10
received each ofthe three exposures oneachofthe test-
ing days.
The CO oximeter provided a method ofrapidly ana-
lyzing blood samples for %COHb, as was required to
monitor the CO exposures. The exposure levels were
set in an attempt toreach COHb levels as measuredby
GC. Because %COHb values obtained by GC and CO
oximetry differ, an average offset was used to deter-
mine CO oximetry target values. For most ofthe study,
l0. 3
_1 j- t t 4--
98
v.vrU
)- 1 .01CARBON MONOXIDE AND MYOCARDIAL ISCHEMIA
Table 9. Individual center results for COHb levels in venous blood samples determined by CO oximeter.'
Air day 2%-COHb-target day 4%-COHb-target day
Center n %COHb SEMb n %COHb SEM n %COHb SEM
After exercise test 1 (sample 2)
Johns Hopkins
Rancho Los Amigos
St. Louis
After exposure (sample 5)
Johns Hopkins
Rancho Los Amigos
St. Louis
22 1.13
18 1.25
23 1.35
22 1.25
18 1.34
23 1.54
0.07 22 1.18
0.09 18 1.18
0.09 22 1.35
0.06 22 3.33
0.07 18 3.13
0.08 22 3.15
0.07 22 1.12
0.09 18 1.22
0.08 23 1.35
0.06 22 5.76
0.07 18 5.56
0.06 23 5.42
After exercise test 2 (sample 6)
Johns Hopkins 22 1.07 0.07 22 2.78 0.07 22 4.79 0.07
Rancho Los Amigos 18 1.13 0.08 18 2.58 0.07 18 4.76 0.10
St. Louis 23 1.26 0.09 22 2.56 0.05 23 4.55 0.10
a Measurements were made on samples taken at the end of exercise test 1, at the end of the exposure period, and at the end of exercise
test 2.
b SEM, standard error ofthe mean.
an offset of 1.0% was used for the 2.2% GC target and
1.3%forthe4.4% GCtarget, givingCOoximetertarget
levels of 3.2 and 5.7%, respectively. The ability to at-
tain the CO oximeter target values is a validation of
this technique (Table 9).
Monitoring of Atmospheric Carbon Monoxide.
The levels ofCO breathed by the subjects inthis study
were measured at all stages ofthe experiments. This
included measuring the background laboratory CO
levelstowhichthesubjects wereexposedduringthe ex-
ercise tests as well as the chamber CO concentrations
during the exposure phase. Carbon monoxide levels
were determined with the use of nondispersive infra-
red analyzers (Bendix Model 3501-5CA, or Beckman
Model 866)thatprovided a continuous recording ofthe
CO concentration. Prior to use each day, the instru-
ments were calibrated with commercially available
standard gases that had been analyzed by the suppli-
ers (Airco, Detroit, MI, or Scott Specialty Gases, San
Bernardino, CA) and were shown to be ± 1% ofthe re-
ported concentration based upon National Institute of
Standards and Technology (NIST) standards. In addi-
tion, cylinders of CO that had been standardized ac-
cordingto the EPA protocol (4) were usedfor daily cali-
bration and to confirm periodically the concentration
ofthe NIST traceable gases. The EPA traceable gases
not only met the requirements forthe NIST gases, but
also had to show consistent values (within 1%) on re-
peated analyses at least 24 hr apart. All ofthese gases
were contained in aluminumcylinders treated with an
antioxidant to prevent production of CO in the cylin-
ders overtime. The zero-CO gasmixtures used were ni-
trogen without carbon dioxide for the Bendix instru-
ments and nitrogen with 0.03% carbon dioxide for the
Beckman analyzer.
Thedailycalibrationoftheanalyzers wascarriedout
using two or three standard gases for each range of ex-
pected use ofthe instrument on CO-exposure days. On
air-exposure days, the analyzers were calibrated with
at least a zero-gas mixture and one standard gas. The
gases were monitoreduntil a stable reading was main-
tained for at least 1 min on the chart recording.
Five times over the 2-year course of testing of sub-
jects, the Rancho Los Amigos center coordinated a
round-robin analysis at all three centers of cylinders
with two unknown concentrations ofCO specially pre-
pared eachtime forthistask. The results ofthese com-
parative tests provided information about the relative
values for monitoring atmospheric levels of CO at all
centers and about the functioning ofthe instruments
that were used throughout the course of the study.
These results indicate that all centers were within 2%
of each other with regard to the range of values and
within 1% when the average difference was used.
A more extensive calibration of the analyzers was
carried out periodically. During these sessions, the
standard gases were calibrated against the EPA proto-
col gases over allthe intended rangesofuseofthese in-
struments. It was the general finding that none ofthe
gases varied from one another, regardless ofthe proto-
col under which they were produced at the supplier.
Also, the gases remained stable for the 2.5 years that
they were used for this study.
The monitoring during exposure at each center was
done in such a way that the gas that was sampled re-
flected the CO concentration that the subject was in-
haling. This was carried out by sampling next to the
head ofthe subject (within 1 to 2 ft) at Johns Hopkins
and St. Louis. At RanchoLos Amigos, sampling was at
a distant site, and the distribution ofCO and the mix-
ing characteristics ofthe chamber were checked every
3 monthstoconfirmthatthere were nogradientsofCO
in the chamber. Similar checks of chamber mixing
were alsoperformed atJohnsHopkinsandSt. Louis, at
less frequent intervals.
Atmospheric levels were continuously monitored
during exercise testing and never exceeded 8 ppm.
During the exposure period, a mean or integrated
value of the atmospheric CO concentration was re-
ported to the nearest part per million. The longest in-
0.05
0.08
0.08
0.08
0.13
0.09
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tervalfromwhich averages werecomputed was 15 min.
All subjects were exposed to the various levels ofCO
in room-sized chambers equipped with CO monitors
andwithtemperature andhumidity controls. The tem-
peratureduring exposurerangedfrom650 to 700 F, and
the relative humidity ranged from 45 to 65%. The air
volume in these rooms was rapidly turned over for at-
mospheric control; the exchange rate variedfrom 15 to
50 times per hour. During the exposures, the seated
subjects could not see the chamber operator or gas
monitors. The subjectsenteredthechambersonly after
the desired level of CO was achieved.
Carboxyhemoglobin Measurements
Gas Chromatography. Other studies that investi-
gated the influence oflow doses ofCO on the exercise
tolerance ofpatients with coronary artery disease used
spectrophotometric techniques for assessingblood lev-
els ofCO (5-7,17-19). Spectrophotometric methods are
not sufficiently sensitive for assessing very low levels
of COHb. The error of analysis for the IL 282 CO oxi-
meter is reported to be 1.0% COHb (20), which is
greater than the expected resting COHb level in non-
smokers. Therefore, forthis study, GC, a more accurate
technique for the measurement ofCO in blood (4), was
used to determine COHb levels. The advantage ofthe
GC methodused in this study is that it is precise (reso-
lutionbetterthan0.01 mlofCO/dL ofblood)andlinear
throughout the entire range ofpotential values ofCO
(up to 100% COHb), without modifying the analytical
technique(21). Also,the GC resultsfromthese samples
are unaffectedby all the factorsthat may influence the
CO oximeter values.
The CO content ofeach sample of venous blood was
measured by GC by the Dahms and Horvath (21) tech-
nique. By this technique, the CO contained in 200 piL
ofblood is released from the hemoglobin by denatura-
tion of the hemoglobin and is then extracted into the
headspace ofthe sealed reaction vial with the use of a
vortex. The headspace containing the CO is eluted
ontothe GC columns. The columns usedfor separating
the CO from the other gases were Porapak Q and mo-
lecularsieve inseries. TheCOdistribution curves were
measured by thermal conductivity sensors; peak
height wasusedforquantification. The system wascal-
ibratedby addingknown amounts ofCO inplace ofthe
blood in a standard reaction vial. All values were cor-
rected to standard temperature and pressure, dry
(STPD) conditions.
Gas chromatographic analysis provided a value for
the CO content of each sample. The CO content was
convertedto%COHbbyusing acalculatedCOcapacity
derived from triplicate measurements of hemoglobin
by the cyanmethemoglobin technique. The capacity
was calculated by the formula capacity = average he-
moglobin (g/dL) x 1.389 mL/g (22).
The binding capacity was verified on a monthly
basis. Samples of fresh whole blood were saturated
withCObyequilibrationfor 10minwith a gas mixture
of99.9% nitrogen and 0.1% CO. This last step reduced
the amount of dissolved CO (unbound to hemoglobin)
to negligible levels, while maintaining saturation of
the hemoglobin with CO. The analysis ofthese satu-
rated samples by GC provided a measurement of the
CO capacity that could be compared to a capacity cal-
culated on the hemoglobin values for these same
samples.
Care was taken in the determination ofhemoglobin
usingthecyanmethemoglobintechnique inthose spec-
imens containing high levels ofCOHb: The full devel-
opmentofcolorrequired4to8hr. Thiswasdetermined
using aBeckmanmodel spectrophotometer, with mea-
surementsevery 10 minfor a 12-hrperiod. These speci-
mens were pipetted, sealed, and stored in the dark
overnight prior to analysis. The measured value aver-
aged 98% of the expected value; the range of values
varied between 93 and 102%. Some of this difference
couldhavebeendue tothepresence ofmethemoglobin,
which was not measured. The agreement between the
techniquesprovided the necessary internal validation
ofthe cyanmethemoglobin technique.
Rather than establish this GC technique at three
separate locations, samples requiring GC analysis
were shipped to the Reference Laboratory in St. Louis
for analysis. This was possible because COHb is very
stable inawell-sealedsyringe. Eventhoughthese sam-
ples would remain stable for weeks, they all were sent
to the reference laboratory within 3 days ofcollection
and analyzed within 3 days ofreceipt.
All sampleswereanalyzedintriplicate oruntilthree
results were attainedthat were within arange of5% of
the average value or 0.02 mL/dL ofblood. The values
used in allthe data analyses fromthis study represent
the mean ofthe three values for each sample. Hemo-
globin determinations were made on each sample. If
the samples yielded inconsistent results, they were
hemolyzed with dry saponin and reanalyzed. Hemoly-
siswith saponin was shown tohave no effect onthe CO
content ofbloodsamples or onthehemoglobincontent,
as measured by the cyanmethemoglobin technique.
Three blood samples from each test visit (visits 2, 3,
and 4) for each subject were analyzed by GC: the sam-
ple taken immediately after the first exercise test
(sample2),the samplecollected atthe endofthe expos-
ure period (sample 5), and the sample collected at the
end ofthe second exercise test(sample 6). The samples
atthe endofeach exercise testwerethoserepresenting
the COHb levels at approximately the time the indica-
tors of myocardial ischemia were measured.
CO Oximetry. The optical method employed by CO
oximeters provides a means ofobtaining approximate
measurements ofCOHb levels rapidly. The IL 282 CO
oximeter (20) was used in this study because of the
need for immediate information on blood COHb levels
andthe extensive use ofthis instrument inthis area of
research by other investigators. Rapid measurements
were needed to determine if subjects' baseline COHb
levels werebelowthecut-offlevel and to determine the
duration ofthe CO-exposure period. These were sam-
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FIGURE 5. Effect ofoxygenating several samples from the same sub-
ject during a CO-exposure protocol (increasing initial COHb val-
ues). Note the consistency in the slope ofthe lines. Also note the
variability in the initial %O2Hb values.
ples 1, 3, and 4 during the three test visits, as shown
in Table 2. Other samples, which were measured by
GC, were also measured by CO oximeter.
Four IL 282 CO oximeters were used in this study:
one at each test center and one at the reference lab-
oratory. The standard operating procedure was as de-
scribed in the IL 282 manual (20). The instrument
operation was checked at the beginning of each work
day, with a control dye solution obtained from a com-
mercial vendor. Thedye solution was analyzedto check
the calibration, and the instrument was adjusted, if
necessary, for hemoglobin concentration.
Considerable effort was made to investigate the fac-
tors affecting CO oximeter measurements of %COHb,
with the goal of improving the accuracy of measure-
ments and the comparability ofvalues among individ-
uals. Ofthe many factors investigated, the O2Hb con-
tent ofthe blood wasfoundtohave a major effect onthe
CO oximeter values for %COHb (Fig. 5).
The relative operation of the instruments at the
three centers was compared with the use of modified
whole human blood standards that were prepared spe-
cifically for this purpose. A method was developed by
the reference laboratory for producing a set of fresh,
whole-blood samples with known amounts of %COHb
determined by GC (T. E. Dahms, in preparation).
Throughout the study, a set of four blood samples,
containing0.5% to8% COHb, wasprovided onice tothe
three test centers every 2 weeks. The first day ofanal-
ysis at each laboratory was the day following ship-
ment. The reference laboratory carried out daily anal-
yses on the samples for 3 days, starting with the day of
shipment. This enabled same-day comparison of data
collected on these standards, in case the standards
showed a change in their optical characteristics that
could result in a change in the value for %COHb. The
reference laboratory included inthe shipmentwiththe
samples the data from the day-1 analysis by both GC
and CO oximetry. This enabled the receiving labora-
tory to identify any problem with its instrument.
These blood standards were not intended to serve as
a means ofcalibration ofthe instruments, but to pro-
vide a means for comparing measurements by the in-
struments ateachofthethreetestcenters andforiden-
tifying problems with the instruments. No attempt
was made to standardize the readings among centers.
The results obtained on these standard sample sets
were transmitted to the Statistical and Data Manage-
ment Center for monitoring and analysis. The results
were alsotransmitted back to the reference laboratory
for the purpose of monitoring the performance of the
instruments.
Exercise Treadmill Testing
General Considerations. After meeting the inclu-
sion/exclusion criteria, the subject was scheduled for
the chamber exposure and exercise-test protocol. All
subjects were screenedby one ofthe cardiologists prior
to randomization. Once the subject was entered, the
entry was considered final and the subject was not re-
moved from the study at a subsequent date except for
the specified criteria described below.
There was no CO exposure on the first exercise test
on all four visits. This provided individual reproduci-
bility data for exercise end points for each subject. A
pretest interim history and 12-lead ECG were done at
each visit toverify thatthe angina and ischemic heart
disease had been stable. If there was evidence of un-
stable angina, the subject wasexcludedfromthe study.
A venous cannula was inserted for the duration of
each day'stesting, andapretest COHb level was deter-
mined to document the lack ofrecent exposure to sig-
nificant levels ofCO. Ifthe COHb level was above the
cut-off level, the subject's visit was cancelled for the
day andrescheduled. Afterthe February 1986 protocol
amendment, ifthe subject failed to develop angina or
an ischemic STchange onthe first test ofany visit, the
visit wasrescheduled andthe exposure andsecond test
for that day were not done. Furthermore, ifthe subject
failed to meet either the angina or ST-change require-
ment or the COHb inclusion criteria on two successive
visits, he was dropped from the study.
The Mason-Likar (23) preexercise supine, sitting,
standing, and hyperventilation 12-lead ECGs were
used to determine if posture- or hyperventilation-in-
duced ST-T-wave changes occurred. The control ECG
recorded at each visit, along with an interim history,
was used to assure that no new coronary event had
transpired since the previous test. The preexercise
standing 12-lead Mason-Likar ECG (including -AVR)
was the baseline reference for all the ST-segment end
point measurements for that day's tests.
Speci.ficDefinitions. ECG ST-SEGMENT RESPONSE.
There are three types of ST changes in the ECG that
are interpreted as being indicative of myocardial is-
_
_
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chemia, referred to collectively in the text as "ST end
point":
Type 1. J-point elevation > 1.0 mm and a horizon-
tal or upsloping ST segment 80 msec after
the J point in a lead in which abnormal Q
waves were not evident;
Type 2. J-point depression > 1.0 mm and a hori-
zontal ordownsloping STsegment 80 msec
after the J point;
Type 3. J-point depression > 1.5 mm and an up-
sloping but depressed ST segment 1.5 mm
below baseline 80 msec after the J point
(the end point in 34 tests). The slow, up-
sloping ST segment depression has been re-
ported to indicate myocardial ischemia in
patients with documented coronary artery
disease (24,25).
ANGINAL CHEST PAIN. The subject was instructed to
report any symptoms to the investigator and to grade
hischestpain on a scale of1 to4 asfollows: a)L-1: onset
ofangina, mild, but recognized as the usual angina-of-
effort pain or discomfort with which the subject is fa-
miliar. b)L-2: same pain; moderately severe, definitely
uncomfortable, but still tolerable. c) L-3: severe an-
ginal pain, at a level that the subject will wish to stop
exercising. d) L-4: unbearable chest pain, the most
severe pain that the subject has felt.
ST AND ANGINA END POINTS. Time to reach the ear-
liest typical qualifying ST change, measured in sec-
onds from the onset of exercise, was determined. The
lead from the visit-1 preexposure tests in which this
occurred was entered as the designated lead, along
withthetypeofSTchange(1, 2, or3). Theleadandtype
of ST change generally remained the same in any
given subject for all exercise tests, on both qualifying
and test visits. In the unusual instance in which the
time to onset ofadifferent type ofST response occurred
earlier in any lead in a subsequent test, the lead and
the type ofresponse were recorded asthe time to ST de-
pression or elevation only ifthis ST response occurred
2 min or more before the usual ST response in the des-
ignated preexposure lead.
Type 1 changes were the end point in two exercise
tests, type 2 in455, and type 3 in 34. In 57 subjects, the
same type ofST response was used in all exercise tests.
In five subjects, both type 2 and type 3 changes were
used; in one subject type 1 and type 2 changes were
used. In fifty-nine subjects, the same leads were used
for the ST end point in all exercise tests. In four sub-
jects, 2 leads were used; in twoofthese subjects,V5 and
V6 were used; in one, V4 and V5 were used; and in one,
V5 and II were used.
The duration ofthe ST change, in seconds, in recov-
ery was also recorded for the designated lead. Similar-
ly, time to the onset of angina, measured in seconds,
from the beginning ofexercise to the onset ofthe ear--
liest recognized angina(level 1) was determined, along
with the duration of angina.
Exercise Testing. The exercise treadmill test was
performed on a standard motorized programmable
treadmill, using the modified Naughton protocol (12),
as shown in Table 10. Subjects exercised for 2 min at
each stage ofthe protocol; each stage was designed to
increase the workload by an estimated 1 MET (basal
metabolic equivalent). The maximum workload on the
protocol was 11 METs at 18 to 20 min. The scale read-
ings for treadmill speed and grade on the electronic
programmer were verified on a regular basis by
manual measurement of actual treadmill speed and
grade. The ECG recording and digitizing system was
calibrated before each recording session.
The 12-lead Mason-Likar ECG (including -AVR) was
recorded throughout the exercise with a commercially
available system (CASE II, Marquette Electronics,
Minneapolis, MN) at Johns Hopkins and St. Louis, or
with anemulationofthis system on a GeneralAutoma-
tion minicomputer system at Rancho Los Amigos. Se-
lected leads were monitored continuously for rhythm
changes by oscilloscope, hard-copy analog tracings, or
both throughout the testing procedure. The Mason-
Likar 12-lead ECG was digitally sampled at 250 Hz or
higher through buffered inputs and with sample and
hold amplifiers that had a frequency response offrom
0.05 Hz to at least 120 Hz, with a common mode re-
jection of 100,000 to 1 or better.
The signal processing consisted of a learning period
when a typical cycle was selected (for all 12 leads). A
template-matching algorithm was then applied to
Table 10. Modified Naughton protocol for exercise treadmill ECG test.
2.0-mph 3.0-mph Estimated Elapsed
grade, grade, Duration, METs, time,
Stage 'A A, min units' min
1 0.0 2 2.0 2
2 0.0 2 3.0 4
3 2.5 2 4.0 6
4 5.0 2 5.0 8
5 7.5 2 6.0 10
6 10.0 2 7.0 12
7 12.5 2 8.0 14
8 15.0 2 9.0 16
9 17.5 2 10.0 18
10 20.0 2 11.0 20
8 MET, resting metabolic equivalent.
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FIGuRE 6. Trend plot of ST-80 measurements for the lead showing
the worst ST-segment changes. The time to onset ofST end point
was measured from this type ofplot. Note that maximal ST dis-
placement is 2 mm.
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FIGURE 7. For the lead showing the worst ST-segment depression,
this is the P-QRS-T-wave complex at baseline (first complex) and
each minute thereafter. The three reference points shown with
each complex represent the PQjunction, J point, and ST-80 mea-
surement (also see Fig. 1).
each of the new 12 ECG incoming signals, with time
alignment around a fiducial multilead QRS detector
trigger. A running updated complex was generated
that included P-QRS-T. The QRS onset and offset (J
point) were determined automatically by the program
and were displayed for verification. The amplitude of
the ST 80 ms after J in the updated beat was plotted
every 3 sec and was recorded as a hard-copy trend plot
for each lead (Fig. 6). In addition, the amplitude ofthe
ST 80 ms was printed out in digital form each minute
(Fig. 7), along with heart rate and the processed 12-
leadwaveforms ofthe ECG. The time, to the nearest 10
sec, from the start of exercise to the onset of ischemic
ST, was determined from the trend plots. A template-
matching cycle selection and running averaged beat
were processed with a continuous measurement and
hard-copy plot of ST at 80 ms after the J point. Hard
copy ofthe unprocessed and processed ECG was made
at a minimum of1-min intervals. Both the unprocessed
and processed ECGs were manually overread, in order
to verify the appropriateness ofthe cycle selection and
signal processing ofthe ECG, the computer-generated
QRS offset (J point), and the ST 80 measurements and
trend plots.
Table 11. Number oftimes exercise wasterminatedforvarious
reasons in a total of 376 exercise tests.
Reason for termination Number of times
Fatigue 79
Angina criterion 306
Falling blood pressure 5
ST > 3 mm 18
Hypertensive blood pressure 6
Subject request 172
Other 42
The criteria for stopping the symptom-limited exer-
cise tests were: a)fatigue, shortnessofbreath, legpain,
or subject's request to stop; b) level 2 angina approach-
ing level 3 and subjectwishing to stop; c) 3-mm ST-seg-
ment shift; d) hypertensive blood-pressure response
(240 systolic or 130 diastolic); e) drop in blood pressure
equal to or greater than 20 mm below peak, confirmed
by a second reading within 20 sec (an elevated resting
blood pressure, usually with anxiety, that stabilized
without symptoms after an initial drop in the first 1 to
2 min of exercise was disregarded); I) significant dys-
rhythmia, that is, supraventricular tachycardia last-
ing more than 10 sec, multifocal preventricular con-
tractions (more than 6 per minute) if associated with
increasing angina or significant ST change, three or
morepreventricularcontractionsin arow, orsecond-or
third-degree AV block; g) symptoms ofpossible central
nervous system dysfunction, such as lightheadedness,
dizziness, ataxia, nausea, andpallor; andh)equipment
failure or poor ECGrecordingthat prevented accurate
interpretation of rate, rhythm, or ST change.
The reasons for termination in 376 exercise tests are
presented in Table 11. Frequently, there was more than
one reasonforendingthe test. Neithercentral nervous
system dysfunction nor arrhythmia were ever a cause
for termination.
BlindedInterpretation and ConsensusReviewof
Electrocardiograms. The cardiologist at each center
whoreviewedthe unprocessed andcomputer-processed
ECG records was blinded to name, date, and exposure
history for test visits. The tracings were analyzed in a
batch; all qualifying tests and tests ofvisits 2 through
4werereviewedat onetime. Visit 1, inwhichtherepro-
ducibility requirement was addressed, was read in an
unblinded fashion. All ofthe exercise ECGs (raw trac-
ings and computer-processed records) for each subject
were reviewed by the cardiologists from at least two
centers. These reviews were done at several consensus
meetings that occurred during the course ofthe study.
The following end points were reviewed at these work-
ing sessions: time ofonset ofan ischemic ST response,
as determined by review ofthe computer-generated ST
trendplots andprocessed ECGs andconfirmedby com-
parison with the raw data; duration ofthe ischemic ST
change inthe recoveryphase; total numberofleadsex-
hibitinganischemicSTresponse; andfourcodedmaxi-
mum ST change and slope, during exercise and recov-
ery, in 12 leads (including AVR).
Since the computerized digital trend plot of ST 80
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wasusedtodefine thetimetoSTendpoint,thecardiol-
ogists' main role in ECG overreading was to evaluate
the trend plot for stability and accuracy, to evaluate
the ST-80 slope, and to define the type ofST response.
The rawdatawerecomparedtothedigitizedcomputer-
processed data at each minute of exercise to confirm
that the signal-processed data conformed to the origi-
nal. The main concern wastoverify that nomajor arti-
fact had been included in the processed data. It was
determined that the noise reduction was such that a
more reliable estimate of ST-80 amplitude and slope
could be made from the computer-processed wave-
forms. Once confirmed by review ofthe raw data, the
processed waveforms were used throughout the study
to define the type of ischemic ST, to confirm the time
to onset ofischemic ST to the nearest minute, and to
code the maximal ST change and slope in each ofthe
12 leads.
The trend plots of ST-80 amplitude were then over-
readto refine the timeto ischemic STtothe nearest 10
sec. Thistime was agreedonby consensus ineach case.
The coded amplitude of the maximal ST 80 and the
type ofischemic STineachofthe 12 ECGleads(includ-
ing -AVR) were also reviewed at these meetings. The
slope ofthe ST 80 was overread as follows: using a 5x
magnifyinglenswithanetched 1-mmscaleatthefocal
plane ofthe magnifier, the baseline ofthe 1-mm scale
was aligned with the ST segment just prior to and at
ST80. TheslopeofST80 wasdefinedasflatifthe slope
ofthisportionofthe STwasequalto ± 0.2. Itwascalled
upsloping when the slope ofthis portion ofthe ST was
greater than 0.2, and downsloping if less than -0.2.
Consensus was reached in each case.
Double-Blind Conditions
The double-blind conditions ofthis study were main-
tained in a rigorous fashion. All personnel involved
with the study were instructed to maintain these con-
ditions and were monitored by the investigators to as-
sure compliance with this requirement. At each ofthe
three centers, the exercise-cardiology personnel were
kept blinded tothe exposure conditions, butthe expos-
ure personnel were not. Communication between the
two groups was restricted to issues oftiming ofcollec-
tion ofblood samples and duration ofexposure. At no
time were the chamber conditions discussed with the
subject or with the exercise-cardiology personnel.
The exposure personnel were instructed and moni-
toredto assure consistent behavior patterns on all ran-
domized days to prevent their giving any subtle indi-
cation to the subjects or other personnel about the
exposure conditions. The length ofexposure on the air
day was randomized in advance, but the end ofthe ex-
posure was not announced until sufficient time had
elapsedforanalysisofthe40-minbloodsample andcal-
culation of the exposure time. The chamber monitor-
ing, blood-sample analysis, and exposure-time calcula-
tion were performed out of sight and hearing of the
exercise-cardiology personnel. The exercise-cardiology
groups remained blinded through the data analysis
phase ofthe study.
Data Collection and Management
Stafffromthe Statistical andDataManagementCen-
ter worked closely with the investigators to design the
data-collection forms. The formswere intended to serve
as a complete recordofeach subject's eligibility forthe
study, medical history, laboratory history, CO expos-
ures, exercisetreadmilltests, andprogressthroughthe
studyfromrandomization to completion ofthe protocol.
Subjects who met the study inclusion criteria were
randomized to exposure orderings after the qualifying
visit. Randomization codes were issued by the staffof
the Statistical and Data Management Center to the
data coordinators at the clinical centers. The random-
ization plancalled for stratification by institution and
by whether or not the subjects had a previous myocar-
dial infarction (MI). Within each ofthese six strata (3
institutions x 2 previous MI statuses), the subjects
were balanced in groups of six so that each ofthe six
possible orders of exposure (air, 2%-COHb target, 4%-
COHb target) was represented.
Datawere entered into aVAX 11/780 computer(Dig-
ital Equipment Corporation) running the UNIX op-
erating system (Bell Laboratories and University of
California, Berkeley) at Harvard Health Sciences
Computing Facility, Boston, MA. The data-entry pro-
gram performed range-checking on individual items
and some cross-validation as data were entered. The
data files that resulted from data entry corresponded
to the data collection forms and were processed (en-
tered, verified, and queried) in weekly batches corre-
sponding with the data submission schedule.
Within afew days ofreceipt, theweekly databatches
were entered intothe computer. To ensure absolute ac-
curacy in this data base, data listings were produced
and visually checked against the data forms. Entry
errors were then corrected in the data base. Logical er-
rors anderrorsthatshowed up incross-validation were
queried at the clinical centers using a special query
form, and these errors too were corrected in the data
base. Data that passed the checking routine and data
that passed after the query routine were advanced to
a final data base for data analysis.
Analysis files were constructed from the data case
and were maintained on-line on the VAX 11/780 com-
puter, the IBM4341 (IBMCorporation), orboth during
data-analysis activity. Magnetic-tape copies of all
analysis files were made. Data were analyzed period-
ically throughout the study, but the results were not
revealed to the clinical investigators until testing was
completed.
Statistical Analysis
Thegoaloftheprimary statistical analysiswastode-
termine whether or not there is an effect on the sub-
jects in the study when they are exposed to CO as com-
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pared to air, as measured by the time to ST end point
(type 1, 2, or 3 ischemic ST-segment changes in the
ECG) andthe time to angina. The measurements were
obtained on 3 separate days. On each day, there was a
preexposure exercise test to obtain baseline measure-
ments and a second exercise test after exposure in the
chamber. Depending on the day, subjects were exposed
to air without elevated CO levels or to CO levels de-
signed to achieve approximately 2% COHb or approxi-
mately 4% COHb at the end ofexercise. The measure-
ments ofboth time to onset of angina and time to ST
end point were compared to their respective baseline
data to obtain the increase or decrease due to the ex-
posure. Finally, the air exposure (no CO added) was
used as a baseline measurement to get the four values
for each subject: decrease in percent at 2% COHb and
4% COHb for the time to onset ofST end point and the
time to angina (as specified in the protocol).
The 2% COHb and 4% COHb analyses are reported
separately. Furthermore, separate analyses are also
given for the three centers. To guard against outliers,
trimmed means were used as summary statistics, with
thetwolargest andtwosmallestobservationstrimmed
(26), as specified in the protocol.
All significance calculations inthe primary analysis
used a one-sided p-value with significance at 0.05,
lookingonlyfor a significant decrease intimebased on
permutation distribution of the trimmed means (27).
The one-sided confidence interval was specified in the
protocol because there was no basis to postulate that
CO would have a beneficial effect on the development
of ischemia (28,29). Since we were concerned with de-
termining whether or not there is a significant de-
crease from zero, we considered all possible ways of as-
signing a plus or minus sign to every observation and
calculated the resulting trimmed means. With m ob-
servations, there are thus 2' points in the sample
space, each point representing an onset of angina
trimmed mean and an ST-segment-change trimmed
mean. The significance of the observed statistic was
then evaluated by considering all 2n points as equally
likely. The above analysis strategy was planned prior
to any subject enrollment (and data collection) and is
robust to outliers and model selection, yet it is effic-
ient. Results of alternative analyses are presented in
Appendix B.
Quality Assurance Procedures
Quality assurance (QA) procedures applied to this
study were defined in the QA Plan developed and im-
plemented during the planning stage ofthe study. The
overall goal ofthe QAPlan wasto assurethatthe study
was carriedout in a mannerthatproduced data ofhigh
and well-documented quality, the conduct ofthe study
was consistent among the centers, and the resultant
data were ofequal reliability. An independent QA Of-
ficer was responsible for overseeing the implementa-
tion of the QA Plan and for monitoring compliance
with the QA Plan as the study progressed.
Asrequiredbythe HEIQAPlan,theproceduresused
to conduct the study were defined in the experimental
protocol, the standard operating procedures, and the
DATA Management Procedures Manual developed for
and appliedto the study. Each ofthese documents was
developed by the investigators and was reviewed and
approvedbyHEI,theinvestigators, andtheQAOfficer.
The protocol defined the purpose and background of
the study, the expected results, the significance ofthe
expected results, and the overall organization of the
studyteam. Itprovidedanoutlineofthemethodologies
tobe usedand a description ofthe data tobe collected.
Standard operating procedures documented all rou-
tine and critical experimental procedures and tech-
niques. They provided specific information on calibra-
tion and maintenance ofinstruments, quality control,
sample handling procedures, and the specific method-
ologies used. The DataManagement Procedures Man-
ual included standardized formsfor the collection and
reporting ofdata. It provided specific direction on the
use of the data collection forms, the flow of data be-
tween the investigators and the Statistical and Data
Management Center, the entry of data into the com-
puter, including verification and storage procedures,
and the primary statistical methods to be used to ana-
lyze the data. Standard operating procedures, data
management procedures, and data collection forms
were prepared in document-control format, with each
having a unique title and identification number.
Changes to the experimental protocol were docu-
mented as protocol amendments to assure that all
study team members had the information needed to
implementthechangesandthatthechangeswere uni-
formly applied at each study center. The amendments
detailed changes to be made, the reasons for making
the changes, and the effective dates of the changes.
Each amendment was approved by the principal in-
vestigators, the QA Officer, and the HEI project man-
ager. The standard operating and data-management
procedureswererevised, asneeded, tocorrespondwith
the amended protocol. Inadvertent or one-time-only
deviationsfromstandardoperatingproceduresandthe
protocolhavebeendocumented inthe studyfiles atthe
test centers. A historical file ofprotocol amendments,
standardoperatingprocedures, data-managementpro-
cedures, and data collection forms was maintained to
ensure that there was a complete record ofall the pro-
cedures used.
Facilities inspections were conducted at each study
center by the QA team to determine whether the
physical facilities were adequate for effective comple-
tion ofthe study. Prestudy on-site inspections at each
center were used to document formally the qualifica-
tionsandexperience ofthepersonnel,theirfamiliarity
withtheprotocol andmethods, andthe adequacyofthe
testing facility. Laboratory inspections, conducted at
approximately 6-month intervals while the study was
in progress, ensured that the quality and integrity of
the data mettherequirementsdefinedbytheQAPlan.
These inspections included monitoring of the actual
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conduct ofthe study, data audits, review ofdata collec-
tion and management procedures, and discussion and
review ofthe QA Plan with the investigators. The data
audit compared the raw data and the reported results
toverify the validity ofthe final report. A primary con-
cern ofthese audits was the determination that clear
data trails exist that demonstrate that the study was
conducted as defined in the protocol, standard operat-
ing procedures, and Data Management Procedures
Manual. Aconfidential inspection report wasprepared
for HEI's Executive Director at the conclusion ofeach
audit. HEI's Executive Director gave each report to the
project manager for the study; she transmittted it to
the appropriate principal investigator. The teport de-
tailed any significant findings and requirements for
corrective action.
The QA group conducted the final quality assurance
audit on the data at the end of the study. A report by
theQAofficer statesthatthe Investigators'Report pre-
pared for the Health Effects Institute (9), upon which
this paper is based, accurately reflects the raw data
and that deviations from the protocol have been con-
sidered and addressed appropriately in the analysis of
the data and interpretation ofthe results ofthe study.
Results
Subjects
Sixty-three male subjects, with a mean age of 62
years (41-75 years), who had stable angina pectoris
and a positive exercise test with ST-segment changes
Table 12. COHb levels in venous blood determined by gas chromatography and by CO oximetry.a
Air day 2%-COHb-target day 4%-COHb-target day
Method n %COHb SEMb n %COHb SEM n %COHb SEM
After exercise test 1 (sample 2)
GC 62 0.64 0.02 62 0.62 0.02 63 0.64 0.02
CO oximeter 63 1.24 0.05 62 1.24 0.05 63 1.23 0.04
After exposure (sample 5)
GC target - 2.2 4.4
GC 59 0.70 0.02 56 2.38 0.05 59 4.66 0.09
CO oximeter 63 1.38 0.04 62 3.21 0.04 63 5.58 0.06
After exercise test 2 (sample 6)c
GC target - 2.0 4.0
GC 63 0.62 0.02 62 2.00 0.05 63 3.87 0.08
CO oximeter 63 1.16 0.05 62 2.65 0.04 63 4.69 0.05
a Measurements were made on samples taken at the end of exercise test 1, at the end of the exposure period, and at the end of exercise
test 2.
b SEM, standard error ofthe mean.
'Median values for %COHb in sample 6 are as follows: GC, air = 0.6, 2%o-COHb target = 2.0, 4%Yo-COHb target = 3.9; CO oximeter,
air = 1.1, 2%-COHb target = 2.6, 4%-COHb target = 4.8.
Table 13. Individual center results for COHb levels in venous blood samples determined by gas chromatography.'
Air day 2%-COHb-target day 4%-COHb-target day
Center n %COHb SEMb n %COHb SEM n %COHb SEM
After exercise test 1 (sample 2)
Johns Hopkins 22 0.60 0.04 22 0.60 0.03 22 0.65 0.04
Rancho Los Amigos 17 0.77 0.03 18 0.69 0.05 18 0.72 0.05
St. Louis 23 0.58 0.04 22 0.57 0.04 23 0.57 0.04
After exposure (sample 5)
Target - 2.2 4.4
Johns Hopkins 21 0.66 0.05 20 2.56 0.08 21 4.91 0.13
Rancho Los Amigos 15 0.78 0.04 14 2.59 0.06 15 4.99 0.10
St. Louis 23 0.68 0.04 22 2.09 0.08 23 4.22 0.17
After exercise test 2 (sample 6)c
Target - 2.0 4.0
Johns Hopkins 22 0.58 0.05 22 2.25 0.06 22 4.00 0.12
Rancho Los Amigos 18 0.71 0.03 18 2.05 0.10 18 4.06 0.14
St. Louis 23 0.58 0.04 22 1.70 0.07 23 3.59 0.13
a Measurements were made in samples taken at the end ofexercise test 1, at the end ofthe exposure period, and at the end ofexercise test 2.
b SEM, standard error ofthe mean.
'Median values for %COHb in sample 6 are as follows: Johns Hopkins, air = 0.60,2%-COHb target = 2.30,4%-COHb target = 3.85; Rancho
LosAmigos, air = 0.70, 2%-COHb target = 2.00, 4%-COHb target = 4.20; St. Louis, air = 0.60, 2%-COHb target = 1.70,4 'Yo-COHb target = 3.60.
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ontheirECGssuggestive ofmyocardial ischemia, com-
pleted all tests and met the protocol criteria (Tables 6
and 7). Each subject had at least one ofthree other spe-
cific indicators of coronary artery disease; 40 had an-
giographic evidence of at least a 70% narrowing in at
least one major coronary artery, 26 had a documented
prior myocardial infarction, and 27 had positive thal-
lium stress tests. Additional information onthese sub-
jects and onthe inclusion and exclusion criteria is pro-
vided inthemethods section(Tables 6 and7). Through-
out the Results section, values are presented as means
+ standard errors.
Carbon Monoxide Exposure
Exposure to CO in these subjects was varied individ-
ually to result in predetermined levels ofCOHb. Table
12 provides information on the mean COHb levels de-
termined by GC and CO oximetry. The COHb levels
measured by GC are more accurate; the CO oximetry
COHb values are presented only for comparison with
related studies. Table 12 shows that the combined
mean COHb levels by GC at the end ofthe second exer-
cise test were 2.00% ± 0.05% and3.87% ± 0.08% forthe
2%- and 4%-COHb target days, respectively. These
values are close to the target levels of 2.0 and 4.0% at
the end ofexercise test 2, definedby the study protocol.
The actual levels atthe end ofthe CO exposure period,
2.38 and 4.66%, are slightly higher than the target
levels of2.2 and 4.4%. At all centers, the mean preex-
posure COHb levels were 0.6 to 0.7%. Table 13 shows
that the mean COHb levels after CO exposures were
higher atJohns Hopkins andRanchoLosAmigosthan
at St. Louis. The data inTable 13 showthatthere is an
offset of 0.4 to 1.2% between GC and CO oximeter
measurements.
The desired CO exposure concentrations were cal-
culated onthebasis ofCO-uptakerate constants deter-
minedduringvisit 1 for each subject. The mean values
and ranges for the CO chamber concentrations are
shown in Table 14. The individual CO exposure con-
centrations onthe2%-COHbtargetdayrangedfrom42
to 202 ppm (mean of 117 ppm) and on the 4%-COHb
targetdayfrom 143 to 357 ppm(mean of253ppm). The
mean chamber concentrations onthe 2%-COHb target
day were 102 ppm at St. Louis, 116 ppm at Rancho Los
Amigos, and 134 ppm at Johns Hopkins. On the 4%-
COHb target day, the chamber concentrations were
237 ppm at St. Louis, 256 ppm at Rancho Los Amigos,
and 267 ppm at Johns Hopkins. The COHb values at
the end ofexercise are lower than those at the end of
exposure due to both respiratory loss ofCO during the
interval betweenthe two measurements and the possi-
bility of transfer of CO into extravascular compart-
ments (30,31).
Ihable 14. Chamber carbon monoxide concentrations.a
Air 2%-COHb target 4%-COHb target
Center n Mean SEMb Range n Mean SEM Range n Mean SEM Range
Combined 62 0.7 0.1 0-2 62 117.4 4.4 42-202 62 252.9 6.1 143-357
Johns Hopkins 22 0.1 0.1 0-2 22 133.9 6.7 84-202 22 267.1 9.6 177-357
Rancho Los Amigos 18 1.3 0.1 1-2 18 115.7 8.3 42-170 18 255.8 12.7 143-315
St. Louis 22 0.8 0.1 0-2 22 102.3 6.5 56-174 22 237.0 9.3 150-315
a Concentrations are given in parts per million.
b SEM, standard error ofthe mean.
Table 15. Effect of carbon monoxide on time to ST end point (combined data).
Change in time
COHb levels at Time to ST end to ST end point
end ofexercise point pre- and post- vs.
pre- and postexposure, preexposure,
postexposure seca sec % Decrease between air and CO days
90% 95%
Exposure Sample Mean Trimmed Trimmed Trimmed Confidence Confidence
day size %COHbb SEMC mean SEM mean SEM mean, %d p-Valuee interval interval
Air 62 Pre 0.64 0.02 Pre 560.0 26.6 16.0 11.6
Post 0.62 0.02 Post 575.9 26.6
2%Yo-COHb target 61 Pre 0.62 0.02 Pre 574.1 26.8 -16.3 13.0 5.1 0.01 1.46, 8.74 0.77, 9.43
Post 2.00 0.05 Post 557.8 25.4
4%Y0-COHb target 62 Pre 0.64 0.02 Pre 562.9 27.6 -52.7 12.7 12.1 <0.0001 9.0, 15.3 8.4, 15.9
Post 3.87 0.08 Post 510.1 25.9
a Median time to ST end point; air, pre = 540, post = 570; 2%-COHb target, pre = 560, post = 524; 4%-COHb target, pre = 540, post = 500.
b CO measured by GC.
c SEM, standard error ofthe mean.
d Median percent decrease: air vs. 2%-COHb target = 6.5; air vs. 4%-COHb target = 13.2. For analysis ofnontrimmed means, see Appendix C.
eOne-sided p-values, as described in "Methods."
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ST-End Point Analyses
The results of the ST-end point analyses are sum-
marized in Table 15. For each subject, the percentage
change between the pre- and postexposure exercise
tests was calculated for each exposure day. Thus, each
individual served as his own control on each day. The
difference betweenthe 2%-COHbday andair-exposure
day was usedforanalysis ofthe effect of2% COHb, and
the difference betweenthe 4%-COHb day andair-expo-
sure day was used for the analysis of the effect of 4%
COHb. A positive percentage indicates a decrease in
time to ST end point due to CO exposure. It should be
noted that the air exposure does not translate to zero
COHb level, but rather gives the level of baseline
COHb, resulting from endogenous CO production and
CO exposure, which averages 0.6% in this sample.
As presented in Table 15, CO exposures that pro-
duced a mean level of 2% COHb resulted in a signifi-
cant decrease in the time to ST endpoint(p = 0.01). Of
the 61 subjects inthe 2% analysis, 42 experienced arel-
ative decrease and 19 experienced a relative increase
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FIGURE 8. Regression ofthe percent change in time to ST end point
between the pre- and postexposure exercise tests [(postexposure
- preexposure)/preexposure] and the measured blood COHb
levels atthe end ofexercise forthe 63subjects combined. The line
represents the average of individual regressions.
on the 2%-COHb day, compared to the air day. On the
air day, there was an average increase of5.2% in time
to ST end point on the postexposure exercise test rela-
tive to the preexposure test. In contrast, after the 2%-
COHb exposure, the time to ST endpoint decreased an
average of0.3%. Thus, the 2%-COHb exposure resulted
in a net 5.1% decrease (Table 15). (Note that because
trimming isapplied after all differences are calculated
for each subject, the postexposure minus preexposure
percentagesreported for air-and 2%-COHb days do not
sum to the mean decrease reported in Table 15.)
At the higher CO exposure level, a significant de-
crease in time to ST end point was also found (p <
0.0001). Ofthe 62 subjects in the 4% analyses, 49 expe-
rienced a relative decrease and 13 experienced a rela-
tive increase. Exposure to CO that produced a mean
level of3.9% COHbresulted in a7.6% decrease in mean
time to ST end point relative to the preexposure test.
Thus, compared to the 5.2% postexposure increase in
mean time to ST end point after the control air expos-
ure, the 3.9%-COHb exposure resulted in a net 12.1%
90
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FIGURE 9. Box-and-whisker plots of percent change in time to ST
endpoint between the pre- andpostexposure exercise tests [(post-
exposure - preexposure)/preexposure] on the air day, 2%-COHb
target day, and 4%-COHb target day. The bar across the box is
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Table 16. Time to respective end points for subjects who had missing data.
Time, sec
Exercise test 1 (preexposure) Exercise test 2 (postexposure)
Subject Exposure sr Anginab MaxC ST Angina Max
101 4%-COHb target - 1020 1039 960 885 1020
105 4%-COHb target - 330 603 480 225 537
110 Air 900 902 990 - 665 1028
201 Air - 605 630 - 727 755
2%-COHb target - 590 655 - 635 673
4%-COHb target 540 365 660 - 380 600
214 2%-COHb target - 452 697 810 499 986
215 4%-COHb target - 1073 1113 920 1005 960
a ST, time to the onset ofST endpoint.
b Angina, time to onset of level 1 angina.
c Max, total duration of exercise.
Table 17. Effect ofcarbonmonoxide onheartrate-systolic bloodpressure doubleproductattheonsetofSTendpoint (combineddata).
Double producta at ST Difference between
end point in pre- and pre- and postexposure % Decrease between
Exposure Sample postexposure exercise tests exercise tests air and CO days
day size Mean SEMb Mean SEM Mean %c SEM p-Valued
Air 61 Pre 16,134 563 214 320
61 Post 16,375 649
2%-COHb target 60 Pre 16,558 620 -151 289 1.0 2.2 0.65
61 Post 16,300 597
4%-COHb target 58 Pre 15,986 575 -632 256 4.4 2.0 0.03
62 Post 15,361 528
a Beats per minute x mm Hg.
b SEM, standard error ofthe mean.
c Contrimmed means.
d Two-sided p-values.
decrease in time to ST end point (Table 15).
To assess a possible dose-response relationship, indi-
vidual regressions were fitted to the three differences
in time to ST end point, pre- versus postexposure,
against the three actual COHb readings. When this
was done, the average of the intercepts was 8.01% ±
2.48%, and the average of the slopes was -3.85% ±
0.63%/%COHb. This relationship is illustrated in Fig-
ure8. Thus, inthisrangeofCOHblevels, there appears
to be, roughly, a 3.9% decrease in time to ST end point
for every increase of 1% in COHb. Figure 9 illustrates
this dose-response relationship.
Six ofthe 63 subjects did not reach the ST end point
in one or more ofthe 376 exercise tests (Table 16). One
subject, 201,reachedtheSTendpointinonlyone ofthe
six exercise tests. Since the analyses are based on the
differencesbetweenpre-andpostexposuretimes, no in-
formation on ST end point is available on this subject,
and thus he is not included in the ST analyses. One
subject, 110, didnotreachthe STendpoint onthe post-
exposure testonthe airday, andfoursubjects, 101, 105,
214, and215, didnotreachthe STendpointonthe pre-
exposure exercise test on one ofthe days they were ex-
posed to CO. In each of these instances, because we
knowthatthese subjectsdidnotreachthe STendpoint
bythe endofexercise,thetotalduration ofexercise was
used instead of the time to ST end point in the anal-
yses. The effect of these substitutions is minimal. If
they produce any effect, their influence on study re-
sults and the statistical analyses will be to underesti-
mate any changes due to CO.
The mean heart rate-systolic blood pressure double
product (beats per minute x mm Hg) at the time ofST
endpoint ispresentedinTable 17. Onthe air-exposure
day, there was a mean 1.2% increase inthe double pro-
duct at the onset of ST end point on the postexposure
test. On the 2%-COHb day, there was no significant
change inthe double product atthe STendpoint. How-
ever, onthe 3.9%-COHb day, there was a 3.4% decrease
inthedoubleproductonthepostexposure exercisetest,
which represents a net 4.4% decrease (p = 0.03) com-
paredtothe air-exposure day. Thus, onthe 3.9%-COHb
day, the threshold ST change occurred both earlier in
the exercise test and at a lower heart rate-blood pres-
sure double product.
Table 18 presents data on the maximum ST ampli-
tude during exercise in the selected ECG lead, and
Table 19 presents data on the sum of the maximum
changes inall leads with ST-segmentchangesequal to
or greater than 0.5 mm. There was an 11% increase in
the maximum amplitude of ST changes on the 2%-
COHb day, compared to the air day (p = 0.002). On the
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lkble 18. Effect of carbon monoxide on maximum ST amplitude.
Maximum ST on pre- Differences between
and postexposure pre- and postexposure 'Yo Increase between
Exposure Sample exercise tests, mm exercise tests, mm air and CO days
day size Mean SEMa Mean SEM Mean %Y, SEM p_Valueb
Air 62 Pre 1.86 0.09
62 Post 1.66 0.09 -0.20 0.05
2%-COHb target 61 Pre 1.85 0.11
61 Post 1.82 0.09 -0.02 0.05 11.4 3.5 0.002
4%-COHb target 61 Pre 1.85 0.10
62 Post 1.88 0.09 +0.03 0.05 17.2 4.1 < 0.0001
a SEM, standard error ofthe mean.
bTwo-sided p-values.
Table 19. Effect of carbon monoxide on summed ST score.
ST scorea in pre- Difference between
and postexposure pre- and postexposure % Increase between
Exposure Sample exercise tests exercise tests air and CO days
day size Mean SEMb Mean SEM Mean %Yo SEM p-ValueC
Air 63 Pre 7.4 0.4 -1.3 0.3
62 Post 6.2 0.4
2%-COHb target 61 Pre 7.3 0.5
61 Post 7.0 0.4 -0.2 0.2 20.8 6.9 0.004
4%-COHb target 62 Pre 7.2 0.5
63 Post 7.0 0.4 -0.2 0.2 23.3 6.9 0.001
a ST score is the sum of the maximum changes in all leads with ST-segment changes > 0.5 mm.
b SEM, standard error ofthe mean.
Two-sided p-values.
TAble 20. Effect of carbon monoxide on duration of ST segment changes.
ST duration in Difference between
pre- and postexposure pre- and postexposure 0%, Increase between
Exposure Sample exercise tests, sec exercise tests, sec air and CO days
day size Mean SEMa Mean SEM Mean AY, SEM p-Valueb
Air 61 Pre 118 20 21 12
61 Post 99 15
2%,-COHb target 61 Pie 118 19
60 Post 107 15 -10 12 61 61 0.32
4%,-COHb target 58 Pre 130 22
62 Post 113 17 -12 11 - 7 32 0.84
a SEM, standard error ofthe mean.
b Two-sided p-values.
3.9% day,there was a 17% increase inthe maximum ST
amplitude, compared to the air day (p < 0.0001). The
summed ST score showed a 21% increase on the 2%-
COHb day (p = 0.004) and a 23% increase on the 3.90/o-
COHb day, compared to the air day (p = 0.001). The
duration ofST-segment changes was measured (Table
20) but no changes in duration were found.
Angina Analyses
Figure 10 illustrates the significant correlation be-
tween change in time to ST end point and change in
time to angina (Spearman rank correlation coefficient
= 0.49, p < 0.0001; Pearson correlation coefficient =
0.49, p < 0.0001). The results for time to onset of an-
gina are presented in Table 21 and in Figure 11. There
was a significant decrease of 4.2% in time to onset of
angina on the 2%-COHb day, compared to the air day
(p = 0.03). Ofthe 62 subjects, 38 experienced a relative
decrease intime to onsetofanginaand 23 arelative in-
crease (one subject had no change). On the 3.9%-COHb
day, there was also a significant decrease in time to
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FIGURE 10. Relationship between percent change in time to ST end
point [(postexposure - preexposure)/preexposure] and the per-
centchange intime to angina [(postexposure - preexposure)/pre-
exposure].
angina, with a mean decrease of7.1% compared to the
air day (p = 0.002). Ofthe 63 subjects, 45 experienced
arelative decrease intime toonset ofanginaand 18 ex-
perienced a relative increase. There were no signifi-
cant differences, however, between the air, 2%-COHb,
and 3.9%-COHb days with respect to heart rate-blood
pressure product at the onset of angina (Table 22).
75
50
C
0
a)
E
C
a)
0)
c
-C
0
a)
I,.) a)
0-
25
0
-25
-50
Air day 2%-COHb- 4%-COHb-
target day target day
FIGURE 11. Box-and-whisker plots of percent change in time to an-,
gina between the pre- and postexposure exercise tests [(postex-
posure - preexposure)/preexposure] on the air day, the 2%-
COHb target day, and the 4%-COHb target day. The bar across
the box is the median, the ends ofthe box are the quartiles, the
lines extend to the furthest points within 1.5 times the inter-
quartile range from the box, and the separated dots represent in-
dividuals outside that range.
Table 21. Effect of carbon monoxide on time to angina (combined data).
Change in
COHb levels at Time to angina time to angina
end ofexercise pre- and post- vs.
pre- and postexposure, preexposure, % Decrease between
postexposure seca sec air and CO days
90% 95%
Exposure Sample Mean Trimmed Trimmed Trimmed Confidence Confidence
day size %Y(,COHbb SEMC mean SEM mean SEM mean, 0%d p-Valuee interval interval
Air 63 Pre 0.64 0.02 Pre 519.0 26.7 -17.4 10.9
Post 0.62 0.02 Post 501.6 24.6
2%,-COHb target 62 Pre 0.62 0.02 Pre 525.2 26.2 -42.8 10.6 4.2 0.027 0.66, 7.94 0.4, 8.74
Post 2.00 0.05 Post 482.4 22.0
4'%,-COHb target 63 Pre 0.64 0.02 Pre 515.0 26.5 -49.6 10.9 7.1 0.002 3.06, 10.94 5.18, 14.46
Post 3.87 0.08 Post 465.4 24.1
a Median time to angina: air, pre = 520, post = 489; 2%,-COHb target, pre = 482, post = 460; 4%-COHb target, pre = 480, post = 440.
b CO measured by GC.
c SEM, standard error ofthe mean.
d Median percent decrease; air vs. 2%o-COHb target = 4.2; air vs. 4'Y,-COHb target = 9.0. For analysis ofnontrimmed means, see Appendix C.
e One sided p-values, as described in "Methods."
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Table 22. Effect of carbon monoxide on heart rate-systolic blood pressure double product at the onset of angina
(combined data).
Double producta at angina in Difference between
pre- and postexposure pre-and postexposure % Decrease between
Exposure Sample exercise tests exercise tests air and CO days
day size Mean SEMb Mean SEM Mean I%,C SEM p-Valued
Air 63 Pre 15,989 583
63 Post 15,225 572 -764 228
2%-COHb target 61 Pre 15,822 596 -444 248 -2.0 1.8 0.26
62 Post 15,365 571
4%-COHb target 63 Pre 15,540 512 -562 190 -1.1 1.7 0.50
63 Post 14,978 493
a Beats per minute x mm Hg.
b SEM, standard error ofthe mean.
c Nontrimmed means.
d Two-sided p-values.
Therewasonlyornesubject(306)withmissingangina
data; he did not experience angina on the preexposure
exercise testonthe 2%-COHbtargetday. Thetotal dur-
ation of time on the treadmill was again used as the
datapoint. The effect ofestimating thisvalue, as inthe
ST analyses, is minimal, and, ifanything, makes the
reported p-values conservative.
We alsoexamined, aswe didforthe STendpoint, the
dose-responserelationshipbetween anginaandCOHb.
The individual regressions resulted in an average in-
terceptof -1% ± 2.11% andanaverageslopeof -1.89%
± 0.81%/%COHb. The average decrease in time to an-
gina pectoris appears to be roughly 1.9% for every 1%
increase in COHb, over the range of COHb studied.
This relationship is illustrated in Figure 12.
Total Exercise Duration
The effect ofCO exposure on total exercise duration
ispresented inTable 23. Onthe air day, the meantotal
exercise duration was 692 ± 27 sec on the preexposure
test and was 680 ± 26 sec on the postexposure test (a
1% decrease). On the 2%-COHb day, there was a 1.7%
± 1.6% decrease (p = 0.29) in the total exercise dura-
tion, compared to the air day. After exposure on the
3.9%-COHbday, there was a 6.2% decrease (p < 0.0001)
in the total exercise duration, compared to the air day.
There were no statistically significant differences be-
tweentestdays, however, with regardtothe heart rate-
systolicbloodpressuredoubleproduct at maximum ex-
ercise (Table 24).
Covariate Analyses
The primary analyses evaluated the effect of COHb
levels on the time to the ST and angina end points.
Data were also collected on other factors that could in-
fluencetheseresults. Thefactorsgenerallyfall intothe
categories of study design variables, anthropometric
characteristics of the subjects, factors related to se-
verity of an individual's coronary artery disease, fac-
tors that could affect cardiovascular performance or
pulmonary function, variables related to the study
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FIGURE 12. Regression ofthe percent change in time to angina be-
tween the pre- and postexposure exercise tests [(postexposure
preexposure)/preexposure] and the measured blood COHb levels
at the end of exercise.
centers, and the actual COHb levels. As described be-
low, the actual COHb level was the most significant
covariate.
The order in which the exposures were assigned to
each subject was randomized to guard against a learn-
ing effect. The average times to reach ST end point for
the preexposure exercise tests were 546 ± 8.3 sec at
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Table 23. Effect of carbon monoxide on total exercise duration.
Total exercise time Change
in pre- and in % Decrease
postexposure tests, time, between air
Exposure Sample sec sec and CO days
day size Mean SEMa Mean SEM Mean % p-Valueb
Air 63 Pre 692 27 -12.1 8.2 - -
Post 680 26
2%,-COHb target 62 Pre 700 26 -27.0 9.7 1.7 0.29
Post 673 24
4',%-COHb target 63 Pre 693 27 -53.0 9.0 6.2 < 0.0001
Post 640 26
a SEM, standard error ofthe mean.
bTwo-sided p-values.
Table 24. Effect of carbon monoxide on heart rate-systolic blood pressure double product at peak exercise.
Double producta at peak Difference in double % Decrease
Exercise in pre- and product (pre- minus between air
Exposure Sample postexposure tests postexposure mean difference) and CO days
day size Mean SEMb Mean SEM Mean % p-Valuec
Air 63 Pre 18,486 649 -285 265 - -
63 Post 18,201 748
2%,-COHb target 62 Pre 18,700 718 61 232 -3.23 0.08
62 Post 18,761 678
4%Y,-COHb target 63 Pre 18,761 637 -569 243 0.23 0.89
63 Post 17,686 590
a Beats per minute x mm Hg.
b SEM, standard error ofthe mean.
'Two-sided p-values.
visit 2, 569 ± 8.5 sec at visit 3, and 580 ± 8.4 sec at
visit 4. The learning trend is apparent (p = 0.02). For
the time to angina, the three averages were: 498 ± 9.1
sec, 528 ± 9.2 and 532 ± 9.1 sec (p = 0.02). For the
analysesthatexaminedtheeffectofCO,therawvalues
were not used, but rather the difference between the
pre- and postexposure values were used. The question,
then, iswhetherthe order inwhich the exposures were
assigned had an effect on these differences. To answer
this question, analyses of covariance were performed
onboththetime toSTendpointandthetimetoangina
for the differences in seconds. In these analyses the
order in which the exposures were assigned, together
with the actual COHb percentage, was tested. In none
ofthe analyses was the order ofexposures significant.
Regressions wereperformedtodeterminewhether or
not the differences found in both the ST end point and
angina analyses couldbe explained by othermeasured
covariates. Four sets (decrease in percentages in time
to ST end point and time to angina for both the
2%-COHbtarget dataandthe4%-COHb targetdata)of
simple regressions were performed(each involving one
covariate). In each case, to guard against possible ef-
fects ofnonlinearity and outliers, we performed a rank
regression with normal scoresforallvariables. Ineach
set of regressions, the individual covariates were the
subject's age, smokinghistory, historyofhypertension,
prior myocardial infarction, occupation, use of beta-
blockers, use ofother medications, height, weight, the
maximal time spent on the treadmill at visit 1, the
average time to angina on three preexposure exercise
tests, QRS duration, sodium level, potassium level,
chloride level, FEV1, percent ofpredicted FEV1, FVC,
percent of predicted FVC, the study center, and the
actual COHb level by GC. The actual COHb level was
significant for the analyses of time to ST end point
(for 2%-COHb target analysis,p = 0.014; for 4%-COHb
target analysis, p = 0.014), but was not significant for
the angina analyses (for 2%- COHb target analysis, p
= 0.86; for 4%-COHb target analysis, p = 0.87). The
only other significant (p < 0.05) covariate was weight
for the time to angina analysis at the 4%-COHb level.
With 84 (4 x 21) regression coefficients, we would ex-
pect an average ofaboutfour tobe significant at 5% by
pure chance, compared to the three that were found.
The fact that the time spent on the treadmill on the
first exercise test ofvisit 1 was not a significant covari-
ate indicates that the percent change due to CO is not
correlated with the severity of limitation of exercise
capacity. This conclusion is also supported by the fact
that the average time to angina in the preexposure ex-
ercise tests of visits 2, 3, and 4 was not a significant
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Table 25. Effect of carbon monoxide on time to ST end point at the three centers.
Time to ST Change intime
COHb levels at end point to ST endpoint
end of exercise pre- and post- vs.
pre- and postexposure, preexposure, %Yo Decrease between
postexposure seca sec air and CO days
90'% 95%
Exposure Sample Mean Trimmed Confidence Confidence
day size COHbb SEMC Mean SEM Mean SEM mean, (%od p-Valuee interval interval
Johns Hopkins University
Air 22 Pre 0.60 0.04 Pre 596.0 48.9 7.1 21.8
Post 0.58 0.05 Post 603.1 50.7
2%-COHb target 22 Pre 0.60 0.03 Pre 601.8 47.7 -29.6 29.3 5.9 0.042 0.27, 11.73 - 0.1, 12.84
Post 2.25 0.06 Post 572.2 47.7
4%-COHb target 22 Pre 0.65 0.04 Pre 610.1 48.0 -88.7 25.7 17.5 < 0.0001 11.67, 22.02 10.36, 22.93
Post 4.00 0.12 Post 521.4 46.7
Rancho Los Amigos Medical Center
Air 17 Pre 0.77 0.03 Pre 580.0 45.7 51.8 24.8
Post 0.71 0.03 Post 631.8 42.8
2%-COHb target 17 Pre 0.69 0.05 Pre 606.8 39.6 - 5.4 17.3 10.8 0.0003 6.08, 17.24 5.18, 18.91
Post 2.05 0.10 Post 601.2 40.7
4%-COHb target 17 Pre 0.72 0.05 Pre 588.4 54.8 -20.8 26.7 10.5 0.008 3.78, 17.84 2.29, 19.62
Post 4.06 0.14 Post 567.6 49.1
St. Louis University
Air 23 Pre 0.58 0.04 Pre 510.6 42.3 - 2.0 13.8
Post 0.58 0.04 Post 508.6 40.0
2%-COHb target 22 Pre 0.57 0.04 Pre 521.2 48.0 -11.3 16.8 -1.1 > 0.5 - 8.44, 5.33 -10.03, 6.53
Post 1.70 0.07 Post 509.9 41.1
4%-COHb target 23 Pre 0.57 0.04 Pre 498.8 41.1 -41.9 11.0 9.0 0.025 4.35, 13.64 3.47, 14.63
Post 3.59 0.13 Post 456.9 38.6
a Median time to ST end point; Johns Hopkins, air, pre = 570.0, post = 555.0; 20,-COHb target, pre = 570.0, post
- 522.0; 4'Y(,-COHb
target, pre = 611.5, post = 480.0. Rancho Los Amigos, air, pre = 600.0, post = 630.0; 2%-COHb target, pre = 600.0, post - 590.0; 4',,-COHb
target, pre = 550.0 post = 540.0. St. Louis, air, pre = 480.0, post = 480.0; 2%,-COHb target, pre = 532.5, post = 480.0; 4"/,,-COHb target, pre
= 490.0, post = 450.0. b CO measured by GC.
cSEM, standard error of the mean.
d Median percent decrease; Johns Hopkins, air vs. 2%Yo-COHb target = 7.7; air vs. 4%Y,-COHb target = 20.3, Rancho Los Amigos, air vs.
2%-COHb target = 8.5; air vs. 4%-COHb target = 12.7. St. Louis, air vs. 2'Y,-COHb target = 1.0; air vs. 4%Y(,-COHb target - 7.6. For analysis
of nontrimmed means, see Appendix A.
e One-sided p-values, as described in "Methods."
covariate. Thus, subjects with varying degrees of car-
diac disease have similar percent effects ofCO on their
exercise capacity.
Individual Center Analyses
Table 25presents data on STendpointby center. The
2%-COHb-target exposure level, compared to the air
day, produced a statistically significant effect on time
toSTendpoint atJohns HopkinsandRancho Los Ami-
gos, but not at St. Louis. The 4%- COHb-target expos-
ure level produced a statistically significant decrease
in time to ST end point at all three centers, with a
range of9.0 to 17.5%. Table 25 shows that the effect on
STendpoint was greater after the 4%-COHb target ex-
posure than after the 2%-COHb target exposure at two
centers, Johns Hopkins and St. Louis, but not at Ran-
cho Los Amigos.
The box-and-whisker plots shown inFigure 13 depict
this analysis. These plots show the overlap among the
centers and incorporate the differing average COHb
levels at the different centers, thus the slight increase
in reading from left to right. Analysis of covariance
wasfirstperformedwiththe rawdifferences in seconds
as responses and the measured COHb levels as covari-
ates. Next, center indicator variables were introduced
as individual covariates. This analysis was repeated
forthe percentdifference asresponses. In neither anal-
ysis did the center prove significant; only the COHb
level was significant.
Table 26 presents results of the angina analyses at
the three centers. The effect ofthe 2%-COHb target ex-
posure is statistically significant at two centers, Johns
Hopkins and Rancho Los Amigos. The 4%-COHb tar-
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FIGURE 13. Box-and-whisker plots ofindividual differences in percentages oftime to ST end point on air day compared to CO days at the three
centers, showingthe meanCOHb level atthe end ofthe exercise test after CO exposure ateach center. Thebar across the box isthe median,
the ends of the box are quartiles, the lines extend to the furthest points within 1.5 times the interquartile range from the box, and the
separated dots represent individuals beyond that range. The dashed line is at a difference of 0. (A) Results for the air versus 20/%-COHb
target day, (B) results for the air versus 4%-COHb target day.
get exposure also had a significant effect at only two
centers, Rancho Los Amigos and St. Louis. The box-
and-whisker plots shown in Figure 14 depict these
analyses. Aswiththe STanalyses, these plots showthe
overlaps among the centers and incorporate the differ-
ing average COHb levels at the different centers. As
with the ST end point, analysis ofcovariance was per-
formed usingthe raw differences, andthen the percent
differences, as responses. In neither analysis did the
center prove significant; again, only the COHb level
was significant.
Discussion
Biological Effects
This study demonstrates, with the use of objective
ECG measurements, the influence of low doses of CO
(2% COHb) on the development ofischemia in subjects
with coronary artery disease. Carbon monoxide expo-
sure caused a reduction inthe time to ischemic ST-seg-
ment changes during exercise (Table 15). The earlier
attainment ofthis level ofischemia and the increase in
the maximal change in ST segments (Table 18) and
summed ST segment changes (Table 19) during exer-
cise indicate that low doses ofCO limit exercise toler-
ance inthis group ofindividuals. Thislimitation isfur-
ther demonstrated at the 3.9%-COHb level, at which
the duration ofthe symptom-limited exercise test was
reduced. The subjective end point of time to onset of
angina was also shortened at both the 2.0%- and 3.9%-
COHb levels. As expected, the ECG and angina end
points are closely correlated (R = 0.49, p < 0.0001)
(Fig. 10) and together strongly suggest that these low
doses ofCO produce a decrease in oxygen availability
to the myocardium in subjects with coronary-blood-flow
limitation. Furthermore, there is a significant dose-re-
sponse relationship between COHb levels and the de-
crease intimeto STendpoint(Fig. 8). There was a 3.9%
decrease in time to ST end point for every 1% increase
in COHb. All of these experimental results indicate
that low doses of CO exposure affect cardiac function
during exercise by facilitating the development of
ischemia. The most likely mechanism responsible for
these changes is a reduction in the oxygen-carrying
capacity oftheblood, but more complexeffectsofCO on
myocardial function cannot be excluded.
Starlingandco-workers performed experiments that
were similar in design to this protocol: subjects with
coronary artery disease exercised twice each day on 2
A.
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FIGURE 14. Box-and-whisker plots ofindividual differences in percentages oftime to angina on air compared to CO days at the three centers,
showing the mean COHb level at the end ofthe exercise test after CO exposure at each center. The bar across the box is the median, the
ends of the box are quartiles, the lines extend to the furthest points within 1.5 times the interquartile range from the box, and the
separated dots represent individuals beyond that range. The dashed line is at a difference of 0. (A) Results for the air versus 2%-COHb
target day; (B) results for the air versus 4%-COHb target day.
days separated by less than 1 week. The study design
permitted analysis ofthe results of repeated exercise
tests between days and between tests on the same day.
Virtually all ofthe cardiovascular and exercise param-
eters reported by Starling had reduced variability
when measured on the same day, relative to tests per-
formed on different days. Starling and co-workers re-
ported that the time to onset of angina and time to
0.1-mV ST-segment change was increased in the sec-
ondtest onthe same day, althoughthe heartrate-blood
pressure double product was unchangeOI t these time
points in the exercise test (11). The results ofStarling
and associates are similar tothe increase intime to ST
end point observed in the present study on exercise
testing after air exposure.
Repeated exercise testing on the same day has been
used for a variety ofpurposes. Wayne and LaPlace (32)
used the method to test the efficacy of atropine in pa-
tients with exercise-induced angina pectoris. The
study ofthe acute effects ofpharmacologic agents has
been the major use ofrepeated exercise testing (33,34).
There has been disagreement regarding the effects of
the initial bout ofexercise on the subsequent exercise
tests performed on the same day. A warm-up phenom-
enon (improvement in performance on the second test)
has been shown by several investigators (11,34-36).
However, other studies have reported no change in per-
formance on subsequent exercise tests (7,32,33,37,38).
These differences in results do not appear to be due to
the interval between tests nor to the type of test.
In this study, the use of repeated exercise tests was
based on the report ofStarling et al. (11). These investi-
gators demonstrated that the variability in the end
points of interest was reduced significantly between
twotestsperformed onthe same dayrelativeto tests on
separate days. The variability in measurement of an-
gina responses during exercise is well known (11). Be-
cause ofthe demonstrated use oftesting twice on the
same day without significant health risks to the sub-
jects, two tests were used to reduce the variability and
thereby increase the power ofthe study design. The po-
tential forthe warm-up phenomenon was addressedby
the use ofa placebo (air) day in the study design. As in
drug testing studies using multiple exercise tests on
the same day, the CO effects were all determined rela-
tive to the placebo (air day) test results.
The physiological significance ofthe use ofthe time
to 1-mm ST segment change in subjects with stable
angina has been demonstrated by Starling et al. (11)
andby Waters et al. (36). These studies reported a high
correlation ofthe product ofheart rate and blood pres-
sure withthetimeto 1-mmSTsegmentchange on mul-
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Table 26. Effect of carbon monoxide on time to angina at the three centers.
COHb levels at Time to angina Change in time
End of exercise pre- and to angina post-
pre- and postexposure, vs. preexposure, % Decrease between
postexposure seca sec air and CO days
90% 95%
Exposure Sample Mean Trimmed Confidence Confidence
day size %COHbb SEMC Mean SEM Mean SEM mean, %d p-Value interval interval
Johns Hopkins University
Air 22 Pre 0.60 0.04 Pre 562.2 57.5 -46.1 16.9
Post 0.58 0.05 Post 516.0 51.2
20/%-COHb target 22 Pre 0.60 0.03 Pre 547.7 53.9 -76.2 19.6 5.2 0.014 0.48, 9.93 - 0.42, 11.03
Post 2.25 0.06 Post 471.4 46.1
4%Yo-COHb target 22 Pre 0.65 0.04 Pre 557.1 51.7 -62.2 18.9 4.6 0.09 -0.32, 10.44 - 2.53, 11.53
Post 4.00 0.12 Post 494.9 49.4
Rancho Los Amigos Medical Center
Air 18 Pre 0.77 0.03 Pre 541.5 43.0 14.7 22.7
Post 0.71 0.03 Post 556.2 41.7
2%-COHb target 18 Pre 0.69 0.05 Pre 555.9 40.6 -35.7 15.7 9.4 0.01 3.18, 16.82 1.78, 18.21
Post 2.05 0.10 Post 520.2 36.3
4%-COHb target 18 Pre 0.72 0.05 Pre 522.9 48.7 -33.0 21.1 10.4 0.002 2.18, 17.44 0.48, 18.73
Post 4.06 0.14 Post 489.9 47.6
St. Louis University
Air 23 Pre 0.58 0.04 Pre 460.0 33.3 -15.0 16.4
Post 0.58 0.04 Post 445.1 31.4
2%Y(,-COHb target 22 Pre 0.57 0.04 Pre 477.6 37.9 -15.2 16.6 - 3.2 > 0.5 -9.44, 3.44 -10.83, 4.93
Post 1.70 0.07 Post 462.4 29.5
40%,-COHb target 23 Pre 0.57 0.04 Pre 468.4 37.0 -50.5 17.4 7.7 0.045 0.28, 14.23 - 1.51, 15.54
Post 3.59 0.13 Post 418.0 26.8
a Median time to angina: Johns Hopkins, air, pre = 535.0, Post = 492.5; 2%-COHb target, pre = 512.5, post = 430.0; 4%-COHb target,
pre = 562.0, post = 452.5, Rancho Los Amigos, air, pre = 545.5, post = 478.5; 2%-COHb target, pre = 500.0, post = 491.5; 4%-COHb target,
pre = 466.0, post = 439.0, St. Louis, air, pre = 450.0, post = 480.0; 2%-COHb target, pre = 448.5, post = 452.5; 4%-COHb target, pre = 470.0,
post = 435.0.
b CO measured by GC.
c SEM, standard error of the mean.
d Median percent decrease; Johns Hopkins, air vs. 2%-COHb target = 2.5; air vs. 4%-COHb target = 4.3, Rancho Los Amigos, air vs.
20/(,-COHb target = 13.4; air vs. 4%Yo-COHb target = 13.1, St. Louis, air vs. 2%-COHb target = 0.1; air vs. 4%-COHb target = 5.3. For analysis
of nontrimmed means, see Appendix A.
eOne-sided p-values, as described in the Methods section.
tiple exercise tests. Subjects with coronary artery dis-
ease who undergo repeated exercise tests show some
variability both in the amount of work that they can
perform and in the time required to reach significant
ST segment changes. However, it has been demon-
stratedthat 1-mm ST segment change occurs at a rela-
tively constant double product regardless of the time
course of the exercise required to reach the level of
double product necessary for significant ST change.
Sincethe doubleproduct is areflectionofthemyocardi-
al work, the use oftime to 1-mm ST change represents
a measurement ofmyocardial ischemia at a work load
independent of training or warm-up effects.
The reduction in double product required to reach a
1-mm ST segment change following 3.9% COHb indi-
cates that significant ischemia had occurred at a lower
level of myocardial work. The limited significance in
the changes in double product observed in these stud-
ies reflects to some extent the fact that the measure-
ments ofblood pressure were carried out every minute.
If continuous measurements of blood pressure had
been made, it might have been possible to see the ex-
pected dose-response ofdouble product relative to the
dose-response inthe time to STwith increasedlevels of
COHb.
Theheartrate-systolicbloodpressure doubleproduct
provides a clinical index of the work of the heart and
myocardial oxygen consumption (39), since heart rate
and blood pressure are two ofthe major determinants
ofmyocardial oxygen consumption (40). Iflow levels of
COHb significantly reduce oxygendelivery tothe myo-
cardium, then the development of ischemia at a lower
double product (or lower level of myocardial oxygen
consumption) should be expected. The results for the
heartrate-systolicbloodpressuredoubleproduct atthe
onset ofSTendpoint showthistrend(Table 17). On the
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3.9%-COHb day, there was a statistically significant
reduction in double product on the postexposure test.
On the 2%-COHb day, there was also a decrease in the
double product, but this change was not statistically
significant. The earlier onset ofischemic ST segment
changes at a lower double product (level ofmyocardial
oxygen consumption) is consistent with the expected
inability of these subjects to increase blood flow to
meet myocardial oxygen demands. In these subjects,
when coronary blood flow reaches its limit, the reduc-
tion in arterial oxygencontent by CO results in earlier
development of ischemia.
Electrocardiographic evidence of ischemia occurred
at lower levels ofexercise with CO exposure than with
ambient air exposure. It is implied that at a constant
level of treadmill exercise, and therefore a constant
myocardial workload, exposure to CO would result in
greater myocardial ischemia (larger decreases in ST
segment). This concept is partially supported by the
analysis of end-of-exercise data. For example, in the
3.9%-COHb experiments, there was a significantly
greater maximal change in ST segments observed at
the end ofexercise (Table 18). This occurred at a lower
workload(Table 23)and at a significantly lower double
product(Table 17). Thesefindingsfurther demonstrate
augmentation of myocardial ischemia by increases in
%COHb.
The primary mechanism responsible for the ability of
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COtodecrease oxygendelivery tothe myocardium isthe
direct reduction inthe oxygen-carryingcapacity ofthe
blood. This occurs even at very low partial pressures of
CO because ofthe high affinity ofhemoglobin for CO
relative to oxygen(41). Several otherfactorsmay influ-
ence myocardial oxygenation andfunction. The combi-
nation ofCO with hemoglobin can influence the avail-
able binding sites for oxygen, increasing the overall
affinityofhemoglobinforoxygen(thatis, aleftwardshift
in the oxygen-dissociation curve). The magnitude ofthis
shift can be calculated from the change in P02 required
tohalf-saturate availablehemoglobin. Inhumans,this
value is approximately 0.35 torr O2/1% COHb (10). In
the present study, this would mean 0.5-torr and 1.1-
torr shifts in the oxygen-dissociation curve for the
2.0%- and 3.9%-COHb levels, respectively. In addition
toreducedoxygendelivery,there isthepotentialforre-
duced tissue uptake of oxygen in the presence of CO.
The uptake of oxygen in cardiac muscle is dependent
upon the availability of myoglobin and the ability to
transferoxygenfrommyoglobin tocytochrome oxidase.
However, it is less likely that cytochrome oxidase is
affected by the low levels of COHb achieved in this
study, since Chance and co-workers (42) have reported
a negligible effect ofCO on this part ofthe respiratory
chain. The additional contributions by these other
factors on oxygen availability and cardiac function are
unknown and require further investigation.
%COHb by optical methods
FIGURE 15. Comparison ofeffect ofCO exposure on time to angina in several studies (see Tables 27 and 28 for more detailed information).
The regression line is based on data from this study.
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Table 27. Comparison of studies evaluating the effect of carbon monoxide on the time to onset of angina in subjects with
coronary artery disease.
%COHb, Effect of CO on
mean ± SD' time to anginab
No. of % Decrease CO day Standard error
Investigators subjects Exposures Spectrophotometry Gas chromatography vs. air day of mean
Aronow and 10 Air/2 hrc 0.8 0.2d - _
Isbell (5) 50 ppm CO/2 hrc 2.7 ± 0.2d - 15 2
Aronow (7) 15 Air/i hr' 1.0 0.1e -
50 ppm CO/1 hr' 2.0 ± 0.2' - 12 1
Anderson et 10 Air/4 hrc 1.3 0.4f - -
al. (6) 50 ppm CO/4 hr' 2.9 ± 0.7f - 21 6
100 ppm CO/4 hrc 4.5 ± 0.8f - 21 6
Kleinman 26 Air/i hrc 1.4 ± 0.5e -
(19,43) (1.4 ± 0.5)
100 ppm CO/1 hrc 3.0 ± 0.5e - 7 4
(2.8 ± 0.5)e
Sheps et al. 23g Air/about 1 hrh 17 7e
(17) 100 ppm CO/hrh 41e _0i 9
about 1 hr (3.6)e
Adams et al. 2ij Air/about 1 hrh 1.6e
(18) (1.6)e
100 or 200 ppm COh 59e- 4' 8
about 1 hr (5.2)e
Allred at al. 63 0-2 ppm CO 1.4 ± 0.4e 0.70 ± 0.19 -
(8,9) mean 0.69/50-70 (1.2 ± 0.4)e (0.62 ± 0.19)
min
42-202 ppm COh 3.2 ± 0.3e 2.38 ± 0.40 5 2
mean 117/50-70 (2.6 ± 0.3)e (2.00 ± 0.41)
min
143-357 ppm COh 5.6 ± 0.5e 4.66 ± 0.62 7 3
mean 253/50-70 (4.7 ± 0.4)e (3.87 ± 0.62)
min
a %COHb at end ofexposure. We calculated SD for Kleinman and Whittenberger (19,43) data. Data were not available to calculate SD for
Sheps (17) and Adams (18) papers. Numbers in parentheses are %COHb at end ofthe exercise test after exposure period.
b The design ofour study (8,9) was the same as the two Aronow studies (5,7) in that it had a pre- and postexposure exercise test each day.
For those studies, we calculated the pairwise percent change between the tests on each day and then, pairwise, subtracted the result on the
CO day from the result on the air day. For the Kleinman (43), Sheps (17), and Adams (18) data, we calculated the pairwise percent change
between the air and CO days. For the Anderson (6) data, we calculated the pairwise percent changes between the randomized air day and
theCOdays(asdidAnderson). We usedthe averageofthetwononrandomizedairdaysforthetwosubjectsforwhomdatafromtherandomized
air day were not available. For comparison with the other studies, the percentages listed in this table for our study are means(see Appendix
B) rather than trimmed means (Table 21). We calculated SEM for all studies.
'Mask exposure.
d IL 182 CO oximeter.
'IL 282 CO oximeter.
f Spectrophotometric method.
g Thirty subjects in study, but angina analyzed in only 19 of them.
h Chamber exposure.
'Not statistically significant by one-tailed t-test.
j Thirty subjects in study, but angina analyzed in only 21 of them.
Comparison with Other Studies
This study was designed to assess the effects of low
doses of CO on exercise function in subjects with coro-
nary artery disease. Thefollowingparameters were in-
corporated into the protocol: a) a large well-defined
study population, drawn from three geographical
areas, with unequivocal evidence of ischemic cardio-
vascular disease; b) accurate assessment of CO expo-
sure and COHb levels; c) exercise testing appropriate
for the subject population; d) objective cardiovascular
end points to assess the effects of CO exposure; e) a
clearly defined protocol for subject testing and the
main data analysis; and ) quality assurance proce-
dures to assure that the protocol and standard oper-
atingprocedures were followed and that data were re-
liable and traceable. Several protocol procedures were
adopted to reduce variability in the data to increase
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Table 28. Comparison of subjects in studies of the effect of carbon monoxide exposure on occurrence of angina
during exercise.
Subject characteristics
No. of Smoking Description of Age,
Study subjects Gender Medication history disease years
Aronow and 10 Male Not described No current Classic exertional 40-55
Isbell (5) smokers angina, CAD (mean = 49)
with > 50% stenosis
of 1 or more major vessels
Aronow (7)
Anderson et al.
(6)
Kleinman and
Whittenberger
(19,43)
15 14 Male
1 Female
10 Male
26 Male
Not described
1 subject took
digitalis; drug
therapy basis
for exclusion
14 on beta-
blockers, 19
on nitrates
No current
smokers
5 smokers
(refrained for
12 hr prior
to exposure)
No current
smokers
Stable angina pectoris
with angiographically
demonstrated CAD;
8 had prior MI
Stable angina pectoris,
positive exercise test
(ST changes); reproducible
angina on treadmill
Ischemic heart
disease, stable
exertional angina
pectoris
25 Male 26 subjects on
5 Female medication; 19
on beta-blockers;
11 on Ca-channel
blockers; 1
long-acting
nitrates
22 Male 25 subjects on
8 Female medication;
19 on beta-
blockers; 13 on
Ca-channel
blockers; 1 on
long-acting
nitrates
No current Ischemia during exer-
smokers cise (ST changes or
abnormal ejection frac-
tion response) and 1 or
more of angiographically
proven CAD; prior MI;
typical angina
No current One or more of
smokers > 70% lesion by
angiography in 1
or more major vessels;
prior MI;
typical angina
or positive exercise
test (ST changes) or both
63 Male 38 subjects on
beta-blockers;
36 on nitrates;
40 on Ca-channel
blockers
No current Stable exertional
smokers angina and positive
exercise test (ST
changes) plus one or more
of > 70% lesion by
angiography in 1 or
more major vessels;
prior MI; positive
thallium stress test
the statistical power of the analyses that were to be
used. Thethree majorprocedures involved an exposure
protocol designed to narrow the range ofCOHb levels,
reproducibility criteria for exercise to eliminate indi-
viduals with variant angina, and repeated exercise
testing on each test day to reduce the variability in
subject response to exercise.
Comparison ofthe results ofthis investigation with
other studies of the influence of low doses of CO on
exercise performance in individuals with coronary
artery disease must be approached cautiously because
ofsubstantial differences in the studies. Table 27 and
Figure 15 compare this study with other studies that
evaluated the effect oflow doses ofCO on time to onset
of angina in subjects with coronary artery disease.
Table 28 describes the characteristics ofthe subjects in
these studies. Caution should be used in interpreting
the percent decrease in time to angina reported by dif-
ferentinvestigators(Table 27)because the exercise test
protocols differed. The subjects in the present study
exercised approximately twice as long, presumably be-
cause a gradual incremental workload was employed
for the exercise stress test. However, insufficient detail
is available from most ofthe other studies to fully sub-
stantiate this assumption.
Ofthe seven studiessummarized inTables 27 and28,
five (5-9,43), including our study, reported that low
doses ofCO decreasedthe time to onset ofangina. This
effect was seen at COHb levels of approximately 2 to
3%, measured by optical methods. These optical mea-
50.0 ± 7.2
Mean = 49.9
49-66
(Mean = 59)
Sheps et al.
(17)
Adams (18)
30
(19 with
angina)
30
(21 with
angina)
36-75
(Mean = 58.2)
58 ± 11
Allred
et al. (8,9)
41-75
(mean = 62.1)
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surementsofCOHbarenotaccurate andshouldbecon-
sidered to be within about 1% COHb ofthe true value.
In our study and the Anderson et al. study (6), more
than one dose ofCO was used. Anderson etal. (6)found
the same decrease in time to angina at both 2.9 and
4.5% COHb, whereas we found a strong dose-response
relation. Because ofthe accuracy ofindividual COHb
values measuredby gaschromatography, we were able
to use individual COHb levels inassessingthe dose-re-
sponse relationship (Fig. 8).
The Sheps et al. (17) and Adams et al. (18) studies,
which did not show an effect ofCO on time to angina,
used higher CO doses (4.1 and 5.9% COHb) than the
five studies that reported an effect. However, the re-
sults of these studies are not incompatible with the
studies reporting an effect (Fig. 15). Because of the
large standard error, alargernumberofsubjectswould
have been needed to detect an effect. In the Adams et
al. study(18), although no significantchangeswere ob-
served using conventional statistical procedures, an
actuarialanalysis, whichallowed inclusionoffoursub-
jectswhodevelopedanginaonly onthe COday, showed
a significant effect of CO on time to angina. In addi-
tion, Adams et al. (18) reported that left ventricular
performance, assessed by radionuclide measurement
ofthe ejection fraction, was reduced during submaxi-
mal exercise after exposure to CO compared to air.
ThetimetoonsetofECGSTsegmentchanges,which
are thought to be indicative ofmyocardial ischemia, is
a more objective indicator than angina. We found a
5.1% decrease (one-sided p = 0.01) at 2.0% COHb and
a 12.1% decrease (one-sidedp < 0.0001) at 3.9% COHb
inthetimetotheonsetofischemic STchanges. Wealso
observed an 11 and 17% increase in the magnitude of
the maximal STamplitude atthe endofexercise at 2%
and3.9%COHb, respectively, butfound noeffect onthe
duration ofST-segment changes. AronowandIsbell re-
ported that ST-segment depression occurred earlier
after CO exposure, compared to normal air, but stated
thatST-segmentdepressionwasnotrigorously quanti-
fied (5). In addition, an increase from 1.30 to 1.45 mm
(not statistically significant) in maximal ST-segment
depression wasreported after CO exposure. Aronow(7)
did not report ST data but stated that ST-segment de-
pression appeared to occur earlier with CO exposure,
after lessexercise, andat alowerheartrate-bloodpres-
sure product. Although the ST data were not quanti-
fied, Anderson (6) stated that "generally, ST-segment
depression appeared earlier and was deeper after one
or both concentrations of CO, compared with air."
Kleinman and Whittenberger (43) reportedthat seven
(of 26) subjects "showed small depressions of the
ST-segment of their ECGs at the point of angina on
both test days, and one subject showed ST-segment de-
pression only on the clean air day." However, the aver-
age ST-segment depression reported was only 0.4 mm,
which is not considered indicative ofmyocardial isch-
emia. Also, the differences were not statistically sig-
nificant. However, more recently, Kleinman et al. (19)
reported astatistically significant decreaseinthetime
to 0.1 mV (1 mm) ST-segment depression in eight sub-
jects inthe same study. The reasonforthe discrepancy
between these two reports on the same subjects is not
clear. Sheps et al. (17)did not find an effect ofCO expo-
sure on the time to 1-mm ST-segment depression, the
maximal ST depression, or the heart rate-blood pres-
sure double product at the time ofST-segment depres-
sion. Adams et al. (18) reported that time to > 1 mm
ST-segment depression and maximal ST-segment de-
pression were similar after CO and air exposures.
One important difference amongthe various studies
is in the number ofsubjects that were evaluated. The
number of subjects in our study enabled detection of
small effects that would not have been found with a
smaller cohort with the variability among subjects
seeninourstudy. Eachofthe individualcentersinthis
study enrolled approximately as many subjects as did
the Sheps study (17), and analysis ofthe data reported
by one ofthem (St. Louis) did not show a reduction in
timeto anginaortimetoSTendpointatthe2%-COHb
target exposure. That center alsohadthe lowest mean
COHb levels (by GC) when compared to the other cen-
ters(Table 10). Also, the CO effects on angina were not
significant at the 5% confidence level at Johns Hop-
kins on the 4%-COHb-target exposure day. The appar-
entlackofconsistencyinresultsfromthethree centers
is probably due to the relatively small number ofsub-
jects and variability in response as well as to differ-
ences inCOHb levels atthe centers(Tables25 and 26).
The COHb levels reported in most ofthe previous in-
vestigations were measured at the end of exposure,
rather than at the time ofangina. Decreases in COHb
levels mayhave occurred, dependingonthetime inter-
valtothebeginningofthe exercise stresstest. The dur-
ation and severity ofexercise would also affect CO loss
caused primarily by exercise-induced hyperventila-
tion. Thus, the ability ofthe COHb levels measured at
the end ofexposure toreflect accuratelythe conditions
at the time ofexercise-induced ischemia is clearly in-
fluenced by these additional factors related to study
design. In this study, both postexposure and postexer-
cise COHb levels are reported (Tables 12 and 13), and
one can see significant decreases in COHb levels be-
tween the two samples.
Another important difference among the studies is
whether or not subjects were maintained on anti-an-
ginal medications. Therapeutic approaches andthe ef-
ficacyoftreatmenthaveevolvedduringthetimeperiod
spanning these studies. Currently employed therapy
may be more effective in preventing ischemia, and
studies using these anti-anginal regimens may be im-
portant for the development ofregulatory standards.
In our study, the Kleinman (19,43), Sheps (17), and
Adams(18)studies, subjects remained on medications,
as indicated inTable 28. In our study, the rationale for
this decision was that the subjects should be studied
under conditions that approximated the usual level of
health care, sothatthe effectswouldbe representative
ofthose that would occur outside ofthe experimental
laboratory. In the Anderson study (6), drug therapy,
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such as propanolol and quinidine, was a basis for ex-
clusion from the study, perhaps indicating a milder
severity ofdisease since their subjects did not require
anti-anginal medication or could tolerate withdrawal
from it. Unfortunately, therapy was not discussed in
the Aronow (7) or Aronow and Isbell (5) reports.
While it is difficult to compare the subject popula-
tions by using data from these published reports, the
subjects in our study were selected by strictly defined
criteria. The purpose ofthese entry criteria was to as-
sure that all subjects had well-documented coronary
artery disease and could provide reproducible experi-
mental dataaboutthe STandanginaendpoints, while
still being representative ofthe general population of
individuals with coronary artery disease. In addition
to stable exertional angina and a positive exercise
treadmill test, all subjects wererequiredtohave one or
more ofthree additional indicators ofischemical myo-
cardial disease: angiographic evidence of70% or more
obstruction ofat least one coronary artery, documented
myocardial infarction, or a positive thallium stress
test. In contrast to the other studies, the Anderson
study (6) included smokers who refrained from smok-
ingfor 12 hr prior to exposure, whereas the other stud-
ies excluded current smokers. The effects of chronic
exposure to CO in cigarette smokers with coronary
artery disease are unknown, and inclusion ofsmokers
in that study makes comparison with other studies
difficult.
The type ofexercise employed to induce angina pec-
torisdifferedamongthese studies. Inourstudy andthe
Anderson study (6), subjects exercised on a treadmill,
whereas a bicycle ergometer was used in the otherfive
studies. It is difficult to evaluate the specific exercise
protocols because ofthe lack of detail provided in the
other reports. However, inferences can be drawn based
upon the performance of the subjects in each study.
Under room air conditions, the modified Naughton ex-
ercise protocol used in this study resulted in an aver-
age duration ofexercise prior to the onset ofangina of
more than 500 sec, compared to 325 sec in the Ander-
son study (6), 312 sec in the Sheps study (17), 226 sec
in the Aronow and Isbell study (5), 323 sec in the Aro-
now study (7), 390 sec in the Kleinman and Whitten-
berger study (19,43), and 288 sec in the Adams study
(18). Some ofthese protocols must have employed rapid
incremental exercise workloads or studied subjects
with severe coronary artery disease whowere very sen-
sitive to exercise. Since only the Kleinman (19,43)
study measured oxygen consumption, it is not possible
to determine the actual level ofexercise at which an-
gina occurred in all ofthe studies. Becausethe exercise
protocols and subjects' exercise capabilities varied
among the seven studies, comparisons of the percent
reduction in time to angina appear to be more useful
than comparisons ofchange in actual time to angina.
This is supported by a finding in the present study of
similar percent changes among subjects with different
exercise capabilities.
The methodology usedby other investigators to mea-
sureSTsegmentchangesmayaccountfortheirfinding
no significant changes in the ECG after CO exposure.
Inthisstudythe meandecrease intimetoSTendpoint
was 30 secon 2.0% COHb and 69 sec at 3.9% COHb. We
measured ST segment changes continuously in 12
ECG leads simultaneously via on-line computer as-
sisted methods. This procedure enabled resolution
within 10 sec inthe determination ofthe STendpoint.
Other investigators collected ECG data every minute;
under such conditions a much larger number of sub-
jects would be needed to detect changes. In addition,
the incremental nature of the exercise protocol that
was used was not chosen according to recommended
guidelines for observation ofthese changes in subjects
with stable angina. Redwood et al. (37) recommended
that increments in progressive exercise tests be no
morethan20watts, whichwasusedinthisstudy. How-
ever, it appears that Sheps et al. (17), Adams et al. (18),
and Kleinman et al. (19,43) usedhigher increments as
judged by information provided in the reports. These
investigators startedthe subjects at a low level ofexer-
cise and then used a large first increment in work to
suit operational needs of their study design. For the
Sheps et al. study (17), the effect of this incremental
protocol was to shorten the exercise time to the onset
ofangina, which has the effect ofincreasing the vari-
ability in the response considerably (44). It therefore
appears as though some of the inconsistencies in the
observations in recent studies are due to study design
differences and to the use ofmeasurement techniques
ofvarying sensitivity.
In summary, ofthe seven studies discussed here, five
demonstrated statistically significant effects of low
levels ofCOHb on time to angina by our analyses. For
avariety ofreasonsdiscussedinthissection, including
the small numbers of subjects, differences in subject
populations, and differences in procedures, method-
ology, and study design, it is not surprising that two
studies did not show an effect on time to angina. None
ofthe otherstudiesprovides substantive analysis ofST
segment changes, which showed significant effects in
this study.
Implications of the Findings
Effects ofCarbonMonoxide onHealthand
Quality of Life: Significance of Results
The clinical significance ofthesefindingsmustbe in-
terpreted with respect to the population studied, the
levels of exercise achieved, and the physiological ef-
fects of the actual CO exposure. All subjects in this
study had evidence of atherosclerotic coronary artery
obstruction, which limits coronary blood flow and re-
duces myocardial function. The increased cardiac out-
put and myocardial oxygen demand required by exer-
cise cannot be met beyond a specific threshold level in
these individuals. The results ofthis study show that
CO exposures producing mean COHb levels of2% pro-
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duce detectable changes in the ischemic threshold, as
assessedby areduction inthe time to STendpoint and
the earlier development of angina pectoris. However,
the relationship between the magnitude of these
changes in exercise function and subsequent altera-
tions in an individual's quality of life is complex and
requires careful consideration.
The magnitude of the change in exercise perfor-
mance produced at 3.9% COHb in this study is similar
to that considered clinically significant when evalu-
atingtheefficacyofantiischemictherapeutic interven-
tions (45-49). Whilethe production ofischemia during
exercise is not necessarily related to major cardiac
events, such as an increased risk ofmyocardial infarc-
tion or an acceleration of mortality, it is generally
agreedthatmyocardial ischemia is detrimental. Inter-
mittent brief periods of ischemia have a cumulative
effect and may cause myocardial necrosis (50). In ad-
dition, myocardial ischemia can predispose an indi-
vidual to ventricular arrhythmias (51), lower the fib-
rillation threshold (52), and may be related to sudden
death (53).
The relationship between exercise capacity, as as-
sessedonatreadmillorbicycleergometer, andthe abil-
ity toperformwork orrecreational activities iscompli-
cated. Unfortunately, there are no well-controlled,
objective studies available to correlate these activities
precisely with different levels of treadmill exercise.
Thus, one is forcedto approximate these relationships.
In addition, although exercise level is best quantified
by direct assessment of oxygen consumption (VO2), it
was felt that the changes in experimental methods
that would have beenrequired to measure V02 during
exercise might have affected the primary cardiac end-
points. Thus, direct measurement ofV02 was not per-
formed, but a modified Naughton protocol (12) was
selectedthat uses agradual stepwise increase inwork-
load that correlates with V02. However, because there
are individual differences in V02 during treadmill ex-
ercise, the precise V02 or METs* used at each level in
the modifiedNaughtonprotocol canonlybeestimated.
Despite these reservations, it is useful to consider the
approximate exercise level at which ischemic changes
occurred inthis studypopulation. Electrocardiographic
evidence ofischemia developed in the average subject
at approximately 5 to 6 METs. Thus, ischemia might
be expectedto occur inthis at-risk populationwhen in-
dividuals performing at light to moderate levels ofac-
tivity were exposed to CO that produced COHb levels
aslowas2%. These exerciselevelsmightbereproduced
by climbing one to two flights of stairs or walking on
level,firmgroundat aslowtomoderate pace(2-3 miles
per hour) for a distance of0.5 to 1 mile. Thus, the sub-
jects recruited for this study are not sedentary, and
would be likely to perform different levels of recrea-
tional or work activity, but could not engage in heavy
*One MET equals 3.5 mL of 02 consumed per kilogram body
weight per minute and is roughly equivalent to the VO2 during rest-
ing conditions.
work. In those individuals with angina pectoris, exer-
tional activity would be self-limited by the develop-
mentofchestpain, whereasthose with silent ischemia
would not experience such a warning signal.
Physicians treating patients with coronary artery
disease try to limit physical activity below a known
ischemic threshold, usually defined by the results of
exercise stress testing. Knowledge of the effect of CO
on objective evidence ofischemia during exercise test-
ing (such as time to ST changes) would therefore have
an impact on the allowable levels of activity recom-
mendedbyphysicians, andthus on the patient's quali-
ty oflife, independent ofsymptoms ofangina pectoris.
Thus, lowlevelsofCOHbproducehealtheffectsthatcan
have significant consequences onthefunctional capac-
ity ofan individual performing activities ofdaily life.
These effects occur with light to moderate levels ofex-
ercisethatareroutinelyperformedbymostindividuals.
Another important finding ofthis study was the fact
that there was a dose-response relationship between
COHb andischemia without evidence ofa measurable
threshold effect. Examination ofthe results that com-
paredthe effectsofincreasingCOHbfrombaseline lev-
els (0.6%)to 2 and 3.9% COHb showed that each incre-
ment produced further changes in objective ECG mea-
sures ofischemia. Thisfindingimpliesthateven small
increments in COHb couldadversely affect myocardial
function and produce ischemia. Thus, increases in
COHb in individuals with high baseline COHb levels,
such as cigarette smokers, might produce deleterious
health effects. Further study in such exposed popula-
tion groups is necessary to investigate this possibility.
Demographic Perspective
An important question concerns the applicability of
these findings to a general population of individuals
with coronary artery disease. While this study was re-
stricted to male nonsmokers with stable angina pec-
toris and reproducible exercise tests, clearly, the bio-
logical effectsofCO exposure areunlikelytobelimited
to this specific population group. Active tobacco smok-
ing was an exclusion criteria for this study because of
high COHblevels in smokers. Thus, it does notprovide
direct information on whether or not smokers with
chronically elevated blood COHb levels respond with
similar decreases in exercise capacity when incremen-
tally subjected to higher CO levels or, less likely,
whether ornotthey developtolerance withchronic CO
exposure. Although men were chosen to minimize the
possibility of false-positive exercise tests, there is no
evidence that womenwith coronary artery disease are
less sensitivetoCO. Inaddition, eventhoseindividuals
withcoronary arterydiseasewhodonotexperience an-
gina during exercise do develop typical ECG evidence
of ischemia. Thus, the results of this investigation
should be applicable to most individuals who develop
ECG changes during exercise treadmill testing.
The fact that all subjects continued to take their
usual anti-ischemic medications also makesthem rep-
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resentative of an ambulatory population receiving
optimal medical carefortheir coronary artery disease.
There is no evidence that medications might affect
theseresults,andananalysisshowednodifferencesbe-
tween subjects who either were or were not receiving
beta-adrenergic blockers. It is also possible that some
medications were protective and that a less well-man-
aged group might have been more sensitive to the ef-
fects ofCO exposure. However, it was beyondthe scope
ofthis study to addressthe important questions ofpos-
sible interactions between antianginal drugs and the
responses to CO exposure.
If the subjects in our study are compared with an-
other large, stable-angina, multicenter study popula-
tion (2982 patients) derived fromthe Coronary Artery
Surgery Study(CASS)registry(54), onefindsthat sub-
jects in this multicenter study are similar in terms of
their baseline characteristics: age, gender, angina se-
verity, incidence ofprior myocardial infarctions, drug
therapy, extentofcoronaryarterydisease, andexercise
performance. In addition, it should be notedthatthese
characteristics are also similar tothose ofgroups ofin-
dividuals with silent ischemia who have ST segment
changes without angina during exercise treadmill
testing, as well as those who develop angina without
STchanges. Thus, theprimary results ofthe study ap-
pear to be applicable to a more general population of
subjects with coronary artery disease and stable an-
gina pectoris.
There were 6.7 million individuals in the United
States with ischemic heart disease, as defined by the
U.S. DepartmentofHealth andHumanServices(55)in
the National Heart Interview Survey of1985. Overall,
they compose 2.9% of the United States population.
This includes individuals known to have silent isch-
emia as well as those with angina pectoris. The pres-
ence ofcardiac disease is in part a function ofthe age
distribution ofthepopulation intheUnitedStates. For
example, the frequency of individuals with ischemic
heart disease is 61.8/1000 among those ages 45 to 64
years, and 138.5/1000 among those 65 years or older.
Because survival in the United States has improved
and the population distribution is shifting toward the
elderly, thefractionofindividualswithage-relateddis-
eases, such as ischemic heart disease, is continuing to
increase.
Relevance of Exposure Conditions
The CO-exposure protocol inthis studywasdesigned
toproducespecificlevelsofCOHb insubjectsattheend
ofexercise. The lowerlevel, 2.0% COHb, is atthe upper
end ofthe range ofvalues expected to occur after 8 hr
ofexposuretoCO at levels meetingthe current NAAQS
(an average of9 ppm over 8 hr)(1). It is also within the
range expected from a 1-hr exposure at 35 ppm (the
level of the 1-hr standard) ifthe subject is exercising
moderately (alveolar ventilation of 20 L/min) which
thus increases the CO-loading rate. Our exposure pro-
tocol was designed to mimic the higher rate ofCO up-
take over a 1-hrperiodbut inrestingsubjects. Because
our subjects were exposed duringrest, a higher level of
atmospheric CO (mean 117) ppm) was required to
achieve 2% COHb in a period of about 1 hr. To attain
4% COHb, subjects were exposed to mean CO levels of
253 ppm at rest.
The low dose ofCO in our study, designed to produce
2% COHb in subjects, was selected for relevance to the
NAAQS for CO. In interpretingthe impact ofour find-
ingsonthepopulation,however,itisnecessarytoknow
the frequency distribution ofCOHb levels in the popu-
lation. Wallace and Ziegenfus (56) summarized CO
data from 36 outdoor monitors and COHb levels in
1528 nonsmokers in 20 U.S. cities with populations
greaterthan 100,000. The datawere collectedbetween
1976 and 1980 as part ofthe Second National Health
and Nutrition Examination Survey (NHANES II).
While some cities had several monitors, the subjects
were not always geographically localized inrelationto
specific atmospheric CO monitors. COHb measure-
mentsonblood samplesfromthese subjectswere made
by spectrophotometry and were adjusted so that aver-
age values agreed with GC measurements ofCOHb in
a subset of200 blood samples. The highest 8-hr mean
COHb level in the 20 cities studied was 1.6%, found in
residents of the District of Columbia, where the two
CO monitorshadmeanlevelsof1.8and3.5ppmforthe
8-hr periodprecedingblood samplingfor COHb levels.
Incontrast, the lowest mean group COHb level, 0.55%,
was found in Des Moines, Iowa, where the mean CO
level was 3.8 ppm. Thus, the average atmospheric CO
levels atthe monitoring stations inthese cities did not
correlate well with the measured COHb levels. This
finding suggests that indoor or microenvironmental
exposure may be more important than the levels mea-
sured by conventional atmospheric monitors.
It is also interesting to examine data from individ-
uals with the highest actual COHb levels (56). In four
ofthe20cities, individualswithCOHblevelsinthetop
5% had mean levels of greater than or equal to 2.0%
COHb: District of Columbia (4.6% COHb), San Diego
(3.00% COHb), Los Angeles (2.77% COHb), and New
YorkCity(Bronx)(2.4% COHb). We do notknowwhether
or notthe source ofCO inthose individuals is ambient
air nor can we necessarily equate these COHb levels
with our GC values. Nonetheless, the COHb levels in
these subjects appear to be in the range that produces
adverse effects in individuals with coronary artery
disease.
AlthoughmanyindividualshadCOHblevelsgreater
than2% inthe 20cities(56), onlyoneofthe 36 monitor-
ing stations reported a mean level above the 8-hr aver-
age standard of9 ppm. This occurred at one ofthe six
Manhattan sites, where the CO level was recorded as
13.2 ppm. Two other Manhattan sites had the next
highestlevelsofthe 36sites, at5.9 and5.2 ppm. Yetthe
COHb levelsofthe Manhattanresidents wererelative-
ly low (1.04% mean) when compared to the COHb
levels ofresidents ofother cities, such as Washington,
DC (1.6% COHb). Thus, the CO monitors did not pro-
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vide an accurate method to predict COHb levels be-
causethey may nothavebeenlocated neartherelevant
sources of CO. Furthermore, individual behavior pat-
terns and activity levels may affect COHb levels. For
example, three ofthe most common sources of indoor
carbonmonoxide are environmental tobaccosmoke, gas
stoves, andattached garages. It isbeyondthe ability of
atmospheric monitoring to detect these microenviron-
ments that can lead to significant carbon monoxide
exposure. Given the limitations of COHb measure-
ment at low concentrations and the inability to relate
ambient CO levels in large cities to COHb levels, the
true prevalence ofbiologically significant COHb levels
elevations in different urbanpopulations is uncertain.
Air-quality standards to limit background CO concen-
trations (as measured at monitoring stations) are un-
likely to prevent localized exposures and are unlikely
to prevent all individuals at risk from experiencing
elevated COHb.
There are individuals who have high risk occupa-
tions relative to exposure to carbon monoxide. Ayres
and co-workers (57) measured COHb levels in more
than 1000 New York City residents. These individuals
included people occupationally exposed to high levels
ofCO, such as policemen, bridge workers, and tunnel
workers. Even among nonsmokers, COHb levels were
higher than those reported by Wallace and Ziegenfus
(56). Forexample,the meanCOHb level innonsmoking
policemen workingincongestedprecincts inNew York
City was 3.4%. Among nonsmoking hospital patients,
whose exposure to ambient CO should be relatively
low, average COHb levels were 1.56%, compared to the
1.04% reported by Wallace andZiegenfus (56)for Man-
hattan residents. Some ofthe differences between the
studiescouldbe due to differences in methods ofCOHb
measurement ortodifferencesinthe studypopulation.
Smoking is a major contributing factor to elevated
COHb levels. Inthe studybyAyres andco-workers(57),
policemen from congested areas who did not smoke
hadCOHblevels of3.14%, whereaspolicemenfrom the
same areas who did smoke had COHb levels of8.11%.
The NHANES IIreport describes average COHb levels
of4.53% insmokers and0.88% innonsmokers(58). The
2.0%- and 3.9%-COHb levels at the end of exercise at-
tained in this study represent levels commonly ob-
served among United States adults who live in urban
environments. Smokers may be a particularly sensi-
tive groupwithrespecttoCO exposure because oftheir
high COHb levels and increased risk for the devel-
opment ofcoronary artery disease. Thus, there are im-
portant questions concerning the health effects ofCO
exposure in smokers and whether or not these indi-
viduals develop physiologic adaptations to chronic CO
exposure.
In summary, the CO-exposure conditions and the re-
sulting COHb levels in this study appear to be within
a realistic range for subsets ofthe adult, nonsmoking,
United States population that are heavily exposed to
traffic orother local sources ofCO. Unfortunately, such
local exposures may be difficult to control with am-
bient air-quality standards. In addition, since very low
levels affect work performance in subjects with coro-
naryarterydisease, one mustalso questionwhetheror
not CO exposures would limit the ability to perform
work in individuals with vascular disease influences
other organ systems other than the heart.
Summary and Conclusions
We report results showing the effects oflow doses of
CO on myocardial ischemia in 63 subjects with docu-
mented coronary artery disease. At the lower dose (2%
COHb), the rate of CO uptake in our subjects at rest
mimics the projected uptake rate in moderately exer-
cising subjects exposed to CO at the level ofthe stan-
dard (35 ppm).
At mean COHb levels of 2%, subjects had a 5% re-
duction in the time to onset of ischemic ST segment
changes inthe ECG, and a 4% reduction intime to on-
set ofanginapectoris, comparedtothe control day. The
90% confidence intervals were 1.5 and 8.7% for ST and
0.7 and 7.9% for angina for the 2%-COHb analysis. At
mean COHb levels of 3.9% subjects showed a 12% de-
crease in time to ST end point and a 7% decrease in
time to angina, compared to the control day. The 90%
confidence intervals were 9.0 and 15.3% forST and 3.1
and 10.9% for angina, for the 3.9%-COHb analysis.
In addition, a significant dose-response relationship
was found for the individual differences in the time to
ST end point, for the pre- versus postexposure exercise
tests, at the three COHb levels (p < 0.0001). For this
range of COHb levels (0.2 to 5.1%), a 3.9 ± 0.6% de-
crease intime to STendpoint occurredfor every 1% in-
crease inCOHb. Thesefindings showthat ischemia, as
measured by both ECG changes and angina, develops
at an earlier stage ofexercise after low doses ofCO ex-
posure than after exposure to air alone.
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Appendix A. Randomization to
Exposure
The randomization plan called for stratification by
institution, and by whether or not the subjects had a
previous myocardial infarction (MI). Within each of
these six strata (three institutions times two previous
MI statuses), the subjects were balanced in groups of
six so that each ofthe six possible orders of exposure
(air, 2%-COHb target, 4%-COHb target) was repre-
sented (Table Al). Consequently, each center received
tworandomizationlists, oneforMIsubjectsand onefor
non-MI subjects. An example ofarandomization list is
shown in Table A2. Randomized order was used to
guard against a learning phenomenon. The results of
the orders ofexposure are reported inthe Methods sec-
tion ofthereport. The order ofexposure waskeptblind
to everyone who did not have an initial need to know
until after the ECG readings had been made.
The randomization plan was not perfectly obeyed.
The Statistical andDataManagement Center sentout
the randomization lists to the three test centers but,
due to a misunderstanding, two ofthe centers usedthe
sample randomization list contained in the protocol
document. Before the error was caught and corrected,
Johns Hopkins had registered five subjects with no
prior MI and three subjects with MI, and Rancho Los
Amigos had registered four patients with no prior MI
and seven patients with MI. However, neither the ran-
domization nor the balancing was compromised. The
effect of the error was that if someone knew that the
wrong randomization list was being used, then the
blinding would have been threatened. Since the same
people knew which randomization list was being used
throughout the study, this error did not add any
problems.
Appendix B. Alternative Analyses
Nontrimmed Mean Analyses
The original protocol for the study laid out plans for
the primary analyses of the percent effect of CO on
time to ST end point and time to angina at two target
COHb levels. These plans includedthe use oftrimmed
means to guard against outliers. The results ofthese
analyses are presented in the Results section. In this
appendix, we presentthe results ofthe analyses ofper-
cent changes in time to ST end point and time to an-
gina that do not use trimmed means. The results for
the 63 subjects who completed all test visits and met
the protocol requirements are shown in Tables Bi and
B2. These are the subjects on whom the results de-
scribed in the Results section ofthe report are based.
Results are also presented for 69 subjects, the 63 sub-
jects who are inthe main analysis, plus 6 subjects who
completedthe test visitsbut didnot meet allthe proto-
colrequirementsinTablesB3 andB4. Inallfourtables
we alsopresent analyses ofthe change intimebetween
air and CO days, as well as percent change in time to
angina and to ST end point.
Table Al. Six possible exposure orderings in three visits.
Ordering Visit 2 Visit 3 Visit 4
1 Air 2%-COHb target 4%-COHb target
2 Air 4%-COHb target 2%-COHb target
3 2%-COHb target Air 4%-COHb target
4 2%-COHb target 4%-COHb target Air
5 4%-COHb target Air 2%-COHb target
6 4%-COHb target 2%-COHb target Air
Table A2. Example of randomization list.
Ordering Visit 2 Visit 3 Visit 4
A Air 4%-COHb target 2%-COHb target
B 2%-COHb target Air 4%-COHb target
C Air 2%-COHb target 4%-COHb target
D 4%-COHb target Air 2%-COHb target
E 2%-COHb target 4%-COHb target Air
F 4%-COHb target 2%-COHb target Air
G 2%-COHb target 4%-COHb target Air
H Air 2%-COHb target 4%-COHb target
I 4%-COHb target Air 2%-COHb target
J 4%-COHb target 2%-COHb target Air
K Air 4%-COHb target 2%-COHbtarget
L 2%-COHb target Air 4%-COHb target
M 4%-COHb target 2%-COHb target Air
N 2%-COHb target 4%-COHb target Air
0 2%-COHb target Air 4%-COHb target
P Air 4%-COHb target 2%-COHb target
Q Air 2%-COHb target 4%-COHb target
R 4%-COHb target Air 2%-COHb target
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Table BH. Effect of carbon monoxide on time to ST end point.a
Change in time to ST
comparison between air and CO days, % Decrease in time to ST
sec between air and CO days
Exposure 95% Confidence 95% Confidence
comparison Mean p-Value" interval Mean % p-Valueb interval
Combined data
Air vs. 2%-COHb target 30.4 0.003 9.20, 51.40 5.1 0.01 0.68, 9.46
Air vs. 4%-COHb target 68.7 < 0.0001 47.06, 90.14 12.9 < 0.0001 8.42, 17.28
Johns Hopkins University
Air vs. 2%-COHb target 36.7 0.04 - 3.71, 76.91 6.1 0.04 -0.78, 13.02
Air vs. 4%-COHb target 95.8 < 0.0001 53.94, 139.66 16.0 < 0.0001 9.50, 22.56
Rancho Los Amigos Medical Center
Air vs. 2%-COHb target 57.2 0.001 23.52, 90.68 12.9 0.001 5.17, 20.69
Air vs. 4%-COHb target 72.5 0.004 21.70, 123.30 13.5 0.02
St. Louis University
Air vs. 2%-COHb target 3.3 0.42 -32.44, 39.04 -2.0 > 0.5 -5.55, 1.45
Air vs. 4%-COHb target 39.9 0.0007 17.37, 62.43 9.3 0.0007 4.07, 14.53
a Same 63 subjects as main analysis, nontrimmed means.
b One-sided p-values.
Table B2. Effect of carbon monoxide on time to angina.a
Change in time to angina
comparison between air and CO days, % Decrease in time to angina
sec between air and CO days
Exposure 95% Confidence 95% Confidence
comparison Mean p-Value" interval Mean % p-Valueb interval
Combined data
Air vs. 2%-COHb target 25.4 0.018 1.65, 48.95 5.0 0.02 0.10, 9.80
Air vs. 4%-COHb target 32.2 0.006 6.88, 57.52 6.6 0.006 1.52, 11.74
Johns Hopkins University
Air vs. 2%-COHb target 30.1 0.024 0.26, 59.95 6.2 0.02 0.03, 12.37
Air vs. 4%-COHb target 16.1 0.22 -25.69, 57.69 4.4 0.10 - 2.53, 11.35
Rancho Los Amigos Medical Center
Air vs. 2%-COHb target 50.3 0.014 5.99, 94.61 11.3 0.01 1.87, 20.77
Air vs. 4%-COHb target 47.7 0.014 5.87, 89.33 9.9 0.02 0.67, 19.11
St. Louis University
Air vs. 2%-COHb target 0.23 0.50 -50.20, 50.60 - 1.5 > 0.5 -11.30, 8.28
Air vs. 4%-COHb target 35.5 0.08 -15.00, 86.00 6.2 0.13 - 4.81, 17.19
a Same 63 subjects as main analysis, nontrimmed means.
b One-sided p-values.
Comparing the results of Tables Bi and B2 with
tables in the results section enables a comparison of
the results of the trimmed-mean analyses with the
analyses ofthe percent change intime to STend point
andtoangina. WithrespecttotimetoSTendpoint,the
differences are small. For example, for the combined
data, at 2% COHb, both trimmed and untrimmed
means showed a 5.1% decrease; at the 3.9%-COHb the
trimmed-mean decrease is 12.1%, andthe nontrimmed-
mean decrease is 12.9%. Whether or not means are
trimmed, 2%-COHb-target exposure didnothave anef-
fect at St. Louis, buteffects are significant, atp< 0.05,
in all other cases.
With respect to angina, again the picture is similar
whetherthetraditionalanalysesorthetrimmed-mean
analyses ofpercent change are used. Forthe combined
data, the mean change in time to angina at 2% COHb
is 5.0%, and the trimmed mean is 4.2%; the mean
change in time to angina 3.9% COHb is 6.6%, and the
trimmed-mean change is 7.1%. The trimmed-mean
analysesgivestatistically significanteffects(p < 0.05)
in all but two instances (4%-COHb target at Johns
Hopkins; 2%-COHb target at St. Louis), and the tradi-
tional analyses give significant effects except forthree
instances (the two above and 4%-COHb target at St.
Louis).
Comparing Tables Bi and B2 with Tables B3 and
B4 shows the difference in results when six subjects
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who did not meet the protocol requirements are in-
cluded in the analyses. With respect to the analyses of
percentchange intimetoSTendpoint, mostofthe sub-
jects who did not meet protocol requirements provided
no ST data. Thus, it is not surprising that the results
are similar; the ST analyses of69 subjects compared to
63 subjects actually add only two subjects at the 2%-
COHb-target exposure and one at the 4%-COHb tar-
get. However, in the angina analyses, eight are added
at the 2%-COHb-target level and six at the 4%-COHb-
target level of exposure. Nonetheless, the results are
similar, and the differences are statistically signifi-
cant in the same instances.
All four tables also present the results ofanalyses of
change intime to angina andto STendpointsbetween
air- and CO-exposure days. These results are similar to
the analyses ofpercentchange, asis seenbycomparing
thep-values under the last two headings in Tables Bi,
B2, B3, and B4. In the ST and angina analyses of 63
subjects (Tables Bi and B2), there was a statistically
significant effect in all the same instances, whether
difference in time or percent difference in time was
used to compare results on air- and CO-exposure days.
In the analysis of69 subjects (Tables B3 andB4), there
was, again, a statistically significant effect in all the
same instances, for both the ST and angina analyses,
whencomparingtime difference to percent time differ-
ence beween days.
Randomized Analysis Allowing for
Blocking
The order in which the exposures were administered
to each subject was tested and found not to be signifi-
cant. As afurtherexamination ofthe effectofthe order
of exposure, randomization tests were performed to
account for the possible induced correlation.
As explained in Appendix A, subjects were stratified
by whether or not they had had a prior myocardial in-
farction. Then, within strata, theorderofexposure was
assigned, at random, in balancedblocks ofthe six pos-
sible orders. The randomization p-values reported in
Table B5 are a result ofpairing subjects within blocks.
The pairing within each block was determined by
when the "other" exposure was administered. So, for
example, for the 2%-COHb-target analysis, the two
Table B5. Effect of carbon monoxide on time to ST end
point and time to angina: block-randomized p-values.
Time-to-
Time-to-ST angina
Analysis p-value p-value
Johns Hopkins University
Air vs. 2%-COHb target 0.042 0.08
Air vs. 4%-COHb target 0.0005 0.14
Rancho Los Amigos Medical Center
Air vs. 2%-COHb target 0.001a 0.004
Air vs. 4%-COHb target 0.01 0.02
St. Louis University
Air vs. 2%-COHb target > 0.5 >0.5
Air vs. 4%-COHb target 0.0049 0.045
a Most extreme attainable in this analysis.
within a block who had the 4%-COHb-target exposure
on the first experimental visit were paired, the two
who had the 4%-COHb-target exposure on the second
experimental visit were paired, and finally, the two
whohadthe 4%-COHb-target exposure onthe third ex-
perimental visit were paired. Ifthe pairing could not
be donebecause ofablock notbeingfilled, the observa-
tion was not paired. This pairing based on when the
"other" exposure wasadministeredyields anunbiased
test, even ifthe order-or the blocking-is important.
In the randomization, the two responses "exposure
day minus air day" for each pair ofsubjects were both
multiplied by +1, or by -1, with equal probability.
These analyses were only performed for the centers
where the samples were relatively small, and where
the effect of blocking should be felt the most. An ex-
amination ofTable B5, in comparison with Tables 19,
20, Bi, and B2, shows that except for the time-to-an-
ginap-value for the air versus 2%-COHb-target expos-
ure, the three analyses yield very comparable results.
The smallest and largestp-values in Table B5 are pro-
portionally different by the same amounts from the
corresponding p-values in Tables 19, 20, Bi and B2.
Appendix C. Effectiveness of
Exposure Protocol
Minimizing the range of end-of-exposure COHb
levels in this study was desirable because the primary
Table Cl. Comparison of actual COHb results with projected results if a fixed-concentration/fixed-time protocol had been used.
2%-COHb-target day 4%-COHb-target day
Actual Calculated Actual Calculated
%COHba %COHbb %COHba %COHbb
Mean 3.1 3.2 5.4 5.6
Median 3.1 3.1 5.6 5.8
Range 2.7-3.6 2.1-4.4 4.4-6.0 4.4-7.7
SD 0.26 0.59 0.41 0.79
SEMC 0.05 0.12 0.08 0.16
a Actual experimental data (individual CO levels/variable time).
b Calculated data using uptake rates determined at visit 1 and assuming a single CO-exposure level and constant time.
c SEM, standard error ofthe mean.
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analysis compared cardiovascular changes at 0.7%
COHb to changes at 2.0% and 4.0% COHb. The more
these CO doses could be cleanly separated, the better.
The extenttowhichtheprotocolmaneuvers, ofvarying
exposure concentration and time, were effective in ac-
complishing this reduction in variability can only be
estimated. We have taken two approaches to estimat-
ing the scatter that would have been obtained ifthese
subjects had been exposed to fixed levels of CO for a
fixed time.
The first approach was to use the data from visit 1,
when all subjects were exposedto 150ppmfor 1 hr. The
range of COHb values obtained after 60 min of expo-
sure demonstrates considerable variability among in-
dividuals in CO uptake. Analysis of data from visit 1
from the St.Louis center shows that, for 24 subjects
studied, the end-of-exposure COHbvaluesrangedfrom
3.8 to 5.8%, with a mean of 4.1% (SD = 0.49). This
range of2.0% among subjects atthe endofa60-min ex-
posure equalsthe difference betweenthe desiredlevels
after exposure to CO used in this study. Therefore, it
suggests that the use of a fixed-exposure/fixed-time
protocol would have been unacceptable.
A second approach was the use ofthe individual up-
takerates actuallymeasured onvisit 1, combinedwith
the actual starting COHb levels, to project a theoreti-
cal end-of-exposure COHb. The predicted levels of
COHb for the St. Louis subjects were calculated for
fixed atmospheric levels ofCO for 60 min ofexposure.
The calculatedend-of-exposure levels were obtainedby
using the average chamber levels of 102 ppm and 237
ppm CO that were used in the study. The uptake-rate
constants determined during the first visit were used
to predict the 60-minvalues. The values of%COHb de-
termined prior to exposure on each day were used as
the start values. This process predicts the effect of ex-
posing these subjects to a constant level of CO for 60
min given the variability in their baseline levels of
%COHb. The calculated results are compared with the
actual results in Table Cl. The range, standard devia-
tion, and standard error are all reduced about 2-fold at
each target level in the actual, compared to the calcu-
lated, results.
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